Rigetti Computing (RGTI) 10-Q/A 30 Nov 22 2022 Q2 Quarterly report (amended) Financial data

Cover Page

Cover Page - shares	6 Months Ended
	Jun. 30, 2022	Aug. 05, 2022
Document Information [Line Items]
Document Type	10-Q/A
Amendment Flag	true
Document Period End Date	Jun. 30, 2022
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	Q2
Entity Registrant Name	RIGETTI COMPUTING, INC.
Entity Central Index Key	0001838359
Current Fiscal Year End Date	--12-31
Document Quarterly Report	true
Document Transition Report	false
Entity File Number	001-40140
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	88-0950636
Entity Address, Address Line One	775 Heinz Avenue
Entity Address, City or Town	Berkeley
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	94710
City Area Code	510
Local Phone Number	210-5550
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	false
Amendment Description	Rigetti Computing, Inc. (together with its consolidated subsidiaries, as the context requires, the “Company,” “we,” “us,” or “our”) is filing this Amendment No. 1 to the Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2022 (as amended, the “Quarterly Report on Form 10-Q/A”) to amend and restate the unaudited interim condensed consolidated financial statements as of June 30, 2022 and for the three and six months ended June 30, 2022, previously included in its Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission (“SEC”) on August 12, 2022 (the “Original Form 10-Q”). This Quarterly Report on Form 10-Q/A also amends certain other Items in the Original Form 10-Q, as listed in “Items Amended in this Quarterly Report on Form 10-Q/A” below. On November 14, 2022, the Company filed a Current Report on Form 8-K disclosing that the financial statements included in the Original Form 10-Q should not be relied upon.
Entity Common Stock, Shares Outstanding		118,244,451
Common Stock [Member]
Document Information [Line Items]
Title of 12(b) Security	Common Stock, $0.0001 par value per share
Trading Symbol	RGTI
Security Exchange Name	NASDAQ
Public Warrant [Member]
Document Information [Line Items]
Title of 12(b) Security	Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share
Trading Symbol	RGTIW
Security Exchange Name	NASDAQ

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands		Jun. 30, 2022	Dec. 31, 2021
Current assets:
Cash		$ 184,020	$ 11,729
Accounts receivable		2,572	1,543
Prepaid expenses and other current assets		4,248	1,351
Forward contract - assets		1,543	0
Deferred offering costs		0	3,449
Total current assets		192,383	18,072
Property and equipment, net		30,583	22,497
Restricted cash		117	317
Other assets		130	165
Goodwill		5,377	5,377
Total assets		228,590	46,428
Current liabilities:
Accounts payable		1,517	1,971
Accrued expenses and other current liabilities		6,018	3,806
Deferred revenue		1,108	985
Debt - current portion		4,226	575
Forward contract - liabilities		0	230
Total current liabilities		12,869	7,567
Debt - net of current portion		25,201	24,216
Derivative warrant liabilities		12,148	4,355
Earn-out liabilities		7,856	0
Other liabilities		416	295
Total Liabilities		58,490	36,433
Commitments and contingencies (Note 5)
Stockholders' (deficit) equity:
Preferred Stock, par value $0.0001 per share; 10,000,000 shares and 0 shares authorized at June 30, 2022 and December 31, 2021, respectively; 0 shares and 0 shares issued and outstanding at June 30, 2022 and December 31, 2021, respectively		0	0
Common stock (2), par value $0.0001 per share; 1,000,000,000 shares and 134,050,472 shares authorized at June 30, 2022 and December 31, 2021, respectively; 117,102,735 shares and 18,221,069 shares issued and outstanding at June 30, 2022 and December 31, 2021, respectively	[1]	11	2
Additional paid-in capital		407,015	135,549
Accumulated deficit		(237,025)	(207,131)
Accumulated other comprehensive gain		99	52
Total stockholders' equity (deficit)	[2]	170,100	(71,528)
Total liabilities, redeemable convertible preferred stock and stockholders' equity (deficit)		228,590	46,428
Redeemable Convertible Preferred Stock [Member]
Current liabilities:
Redeemable convertible preferred stock (2), par value $0.0001 per share; 0 shares and 80,974,757 shares authorized at June 30, 2022 and December 31, 2021, respectively; 0 shares and 77,696,679 shares issued and outstanding at June 30, 2022 and December 31, 2021, respectively	[1]	$ 0	$ 81,523
[1]Shares of legacy Redeemable Convertible Series C Preferred Stock, Redeemable Convertible Series C-1 Preferred Stock, legacy Class A common stock, and legacy Class B common stock have been retroactively restated to give effect to the Business Combination.[2]For discussion on the restatement adjustments, see Note 1 — Description of Business — Restatement of Condensed Consolidated Financial Statements and Immaterial Correction of Prior-Period Errors

CONDENSED CONSOLIDATED BALANC_2

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares	Jun. 30, 2022	Dec. 31, 2021
Preferred stock, par value	$ 0.0001	$ 0.0001
Preferred stock, authorized	10,000,000	0
Preferred stock, shares issued	0	0
Preferred stock, Outstanding	0	0
Common stock par or stated value per share	$ 0.0001	$ 0.0001
Common stock, shares authorized	1,000,000,000	134,050,472
Common stock, issued	117,102,735	18,221,069
Common stock, outstanding	117,102,735	18,221,069
Redeemable Convertible Preferred Stock [Member]
Preferred stock, par value	$ 0.0001	$ 0.0001
Preferred stock, authorized	0	80,974,757
Preferred stock, shares issued	0	77,696,679
Preferred stock, Outstanding	0	77,696,679

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands		3 Months Ended			6 Months Ended
		Jun. 30, 2022		Jun. 30, 2021	Jun. 30, 2022		Jun. 30, 2021
Revenue		$ 2,134		$ 1,540	$ 4,238		$ 3,900
Cost of revenue		873		365	1,287		637
Total gross profit		1,261		1,175	2,951		3,263
Operating expenses:
Research and development		12,747		7,496	26,673		14,431
General and administrative		12,785		2,711	24,345		5,232
Sales and marketing		1,487		644	2,963		957
Total operating expenses		27,019		10,851	53,981		20,620
Loss from operations		(25,758)		(9,676)	(51,030)		(17,357)
Other (expense) income, net:
Interest expense, net of interest income		(1,040)		(405)	(2,244)		(481)
Change in fair value of derivative warrant liabilities		7,980		0	11,750	[1]	0
Change in fair value of earn-out liability		6,566		0	12,557	[1]	0
Transaction costs		0		0	(927)		0
Other income (expense)		0		7	0		(23)
Total other income (expense), net		13,506		(398)	21,136		(504)
Net loss before provision for income taxes		(12,252)		(10,074)	(29,894)		(17,861)
Provision for income taxes		0		0	0		0
Net loss		$ (12,252)	[1]	$ (10,074)	$ (29,894)	[1]	$ (17,861)
Weighted average shares used in computing net loss per share attributable to common stockholders – basic	[2]	114,096,390	[1]	21,977,123	84,060,966	[1]	21,912,665
Weighted average shares used in computing net loss per share attributable to common stockholders – diluted	[2]	114,096,390	[1]	21,977,123	84,060,966	[1]	21,912,665
Net loss per share attribute to common stockholders - basic		$ (0.11)		$ (0.46)	$ (0.36)		$ (0.82)
Net loss per share attribute to common stockholders - diluted		$ (0.11)		$ (0.46)	$ (0.36)		$ (0.82)
[1]For discussion on the restatement adjustments, see Note 1 — Description of Business — Restatement of Condensed Consolidated Financial Statements and Immaterial Correction of Prior-Period Errors[2]Weighted-average shares have been retroactively restated to give effect to the Business Combination.

CONDENSED CONSOLIDATED STATEM_2

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS - USD ($) $ in Thousands	3 Months Ended			6 Months Ended
	Jun. 30, 2022	[1]	Jun. 30, 2021	Jun. 30, 2022	[1]	Jun. 30, 2021
Net loss	$ (12,252)		$ (10,074)	$ (29,894)		$ (17,861)
Other comprehensive gain (loss):
Foreign currency translation gain (loss)	38		(2)	47		50
Comprehensive loss	$ (12,214)		$ (10,076)	$ (29,847)		$ (17,811)
[1]For discussion on the restatement adjustments, see Note 1 — Description of Business — Restatement of Condensed Consolidated Financial Statements and Immaterial Correction of Prior-Period Errors

CONDENSED CONSOLIDATED STATEM_3

CONDENSED CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' (DEFICIT) EQUITY - USD ($) $ in Thousands		Total		Revision of Prior Period, Adjustment [Member]	Newly Stated [Member]	[1]	Common Stock	Common Stock Revision of Prior Period, Adjustment [Member]	Common Stock Newly Stated [Member]	[1]	Additional Paid-In Capital		Additional Paid-In Capital Revision of Prior Period, Adjustment [Member]		Additional Paid-In Capital Newly Stated [Member]	[1]	Accumulated Other Comprehensive Gain (Loss)	Accumulated Other Comprehensive Gain (Loss) Newly Stated [Member]	[1]	Accumulated Deficit		Accumulated Deficit Newly Stated [Member]	[1]	Preferred Stock [Member] Redeemable Convertible Preferred Stock [Member]	Preferred Stock [Member] Redeemable Convertible Preferred Stock [Member] Revision of Prior Period, Adjustment [Member]	Preferred Stock [Member] Redeemable Convertible Preferred Stock [Member] Newly Stated [Member]	[1]
Beginning balance at Dec. 31, 2020		$ (32,256)			$ (32,256)			$ 2	$ 2		$ 133,144		$ (2)		$ 133,142		$ 5	$ 5		$ (165,405)		$ (165,405)		$ 81,523		$ 81,523
Beginning balance, shares at Dec. 31, 2020							20,975,317	(4,467,972)	16,507,345															98,726,505	(21,029,826)	77,696,679
Issuance of common stock upon exercise of stock options		26									26
Issuance of common stock upon exercise of stock options, shares							118,566
Stock-Based Compensation		597									597
Foreign currency translation gain (loss)		52															52
Net loss		(7,787)																		(7,787)
Ending balance at Mar. 31, 2021		(39,368)					$ 2				133,765						57			(173,192)				$ 81,523
Ending balance, shares at Mar. 31, 2021							16,625,911																	77,696,679
Beginning balance at Dec. 31, 2020		(32,256)			(32,256)			$ 2	$ 2		133,144		(2)		133,142		5	5		(165,405)		(165,405)		$ 81,523		$ 81,523
Beginning balance, shares at Dec. 31, 2020							20,975,317	(4,467,972)	16,507,345															98,726,505	(21,029,826)	77,696,679
Foreign currency translation gain (loss)		50
Net loss		(17,861)
Ending balance at Jun. 30, 2021		(48,832)					$ 2				134,377						55			(183,266)				$ 81,523
Ending balance, shares at Jun. 30, 2021							17,076,119																	77,696,679
Beginning balance at Mar. 31, 2021		(39,368)					$ 2				133,765						57			(173,192)				$ 81,523
Beginning balance, shares at Mar. 31, 2021							16,625,911																	77,696,679
Issuance of common stock upon exercise of stock options		90									90
Issuance of common stock upon exercise of stock options, shares							338,979
Issuance of common stock upon exercise of common stock warrants (Share)							111,229
Issuance of common stock upon exercise of common stock warrants		1									1
Stock-Based Compensation		521									521
Foreign currency translation gain (loss)		(2)															(2)
Net loss		(10,074)																		(10,074)
Ending balance at Jun. 30, 2021		(48,832)					$ 2				134,377						55			(183,266)				$ 81,523
Ending balance, shares at Jun. 30, 2021							17,076,119																	77,696,679
Beginning balance at Dec. 31, 2021		(71,528)	[2]		(71,528)	[2]		$ 2	$ 2		135,551	[2]	(2)	[2]	135,549	[2]	52	52		(207,131)	[2]	(207,131)	[2]	$ 81,523		$ 81,523
Beginning balance, shares at Dec. 31, 2021							23,153,127	(4,932,058)	18,221,069															98,726,505	(21,029,826)	77,696,679
Issuance of common stock upon conversion of legacy Series C and Series C-1 preferred stock in connection with the Business Combination		81,523	[2]				$ 6				81,517	[2]												$ (81,523)
Issuance of common stock upon exercise of stock options	[2]	574									574
Issuance of common stock upon exercise of stock options, shares							1,123,539
Issuance of common stock upon exercise of legacy Rigetti common stock warrants	[2]	28									28
Issuance of common stock upon exercise of legacy Rigetti common stock warrants, shares							2,234,408
Issuance of common stock upon conversion of legacy Series C and Series C-1 preferred stock in connection with the Business Combination, shares							57,380,563																	(77,696,679)
Issuance of common stock through Business Combination and PIPE financing, net of transaction costs and derivative liabilities	[2]	159,538					$ 3				159,535
Issuance of common stock through Business Combination and PIPE financing, net of transaction costs and derivative liabilities, shares	[2]						34,850,706
Stock-Based Compensation	[2]	11,481									11,481
Foreign currency translation gain (loss)		9	[2]														9
Net loss	[2]	(17,642)																		(17,642)
Ending balance at Mar. 31, 2022		163,983	[2]				$ 11				388,684	[2]					61			(224,773)	[2]			$ 0
Ending balance, shares at Mar. 31, 2022							113,810,285																	0
Beginning balance at Dec. 31, 2021		$ (71,528)	[2]		$ (71,528)	[2]		$ 2	$ 2		135,551	[2]	$ (2)	[2]	$ 135,549	[2]	52	$ 52		(207,131)	[2]	$ (207,131)	[2]	$ 81,523		$ 81,523
Beginning balance, shares at Dec. 31, 2021							23,153,127	(4,932,058)	18,221,069															98,726,505	(21,029,826)	77,696,679
Issuance of common stock upon exercise of stock options, shares		1,353,145
Foreign currency translation gain (loss)	[2]	$ 47
Net loss		(29,894)	[2]	$ (9,450)
Ending balance at Jun. 30, 2022		$ 170,100	[2]	(3,725)			$ 11				407,015	[2]					99			(237,025)	[2]			$ 0
Ending balance, shares at Jun. 30, 2022		113,810,285					117,102,735																	0
Beginning balance at Mar. 31, 2022		$ 163,983	[2]				$ 11				388,684	[2]					61			(224,773)	[2]			$ 0
Beginning balance, shares at Mar. 31, 2022							113,810,285																	0
Issuance of common stock upon exercise of stock options	[2]	62									62
Issuance of common stock upon exercise of stock options, shares							229,606
Issuance of common stock upon release of RSUs (Share)							1,360,634
Issuance of common stock upon exercise of common stock warrants (Share)							1,702,210
Issuance of common stock upon exercise of common stock warrants	[2]	5,011									5,011
Reclassification of loan and security agreement warrants to equity	[2]	6,370									6,370
Settlement of the first tranche of forward contract	[2]	(3,305)									(3,305)
Capitalization of deferred costs to equity upon share issuance	[2]	(848)									(848)
Stock-Based Compensation	[2]	11,041									11,041
Foreign currency translation gain (loss)		38	[2]														38
Net loss		(12,252)	[2]	(2,278)																(12,252)	[2]
Ending balance at Jun. 30, 2022		$ 170,100	[2]	$ (3,725)			$ 11				$ 407,015	[2]					$ 99			$ (237,025)	[2]			$ 0
Ending balance, shares at Jun. 30, 2022		113,810,285					117,102,735																	0
[1]Shares of legacy Redeemable Convertible Series C Preferred Stock, Redeemable Convertible Series C-1 Preferred Stock, legacy Class A common stock, and legacy Class B common stock have been retroactively restated to give effect to the Business Combination.[2]For discussion on the restatement adjustments, see Note 1 — Description of Business — Restatement of Condensed Consolidated Financial Statements and Immaterial Correction of Prior-Period Errors

CONDENSED CONSOLIDATED STATEM_4

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2022	[1]	Jun. 30, 2021
Cash Flows from Operating Activities:
Net loss	$ (29,894)		$ (17,861)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	2,978		2,362
Stock-based compensation	22,522		1,118
Change in fair value of earnout liability	(12,557)		0
Change in fair value of forward contract	(5,077)		0
Change in fair value of derivative warrant liabilities	(11,750)		0
Amortization of debt issuance costs	667		0
Changes in operating assets and liabilities:
Accounts receivable	(1,030)		(241)
Prepaid expenses and other current assets	(2,898)		(530)
Other assets	34		(36)
Deferred revenue	123		(119)
Accounts payable	(882)		709
Accrued expenses and other current liabilities	2,557		692
Other liabilities	122		(192)
Net cash used in operating activities	(35,085)		(14,098)
Cash Flows from Investing Activities:
Purchases of property and equipment	(10,636)		(3,744)
Net cash used in investing activities	(10,636)		(3,744)
Cash flows from financing activities
Proceeds from Business Combination, net of transaction costs paid	225,604		0
Transaction costs paid directly by Rigetti	(17,428)		0
Proceeds from issuance of notes payable	5,000		20,000
Payments on debt issuance costs	(85)		0
Payment on loan and security agreement exit fees	(1,000)		0
Proceeds from issuance of common stock upon exercise of stock options and warrants	5,675		117
Net cash provided by financing activities	217,766		20,117
Effect of changes in exchange rate on cash and restricted cash	46		41
Net increase in cash and restricted cash	172,091		2,316
Cash and restricted cash at beginning of period	12,046		24,394
Cash and restricted cash at end of period	184,137		26,710
Supplemental disclosure of cash flow information:
Cash paid for interest	1,708		488
Supplemental disclosure of non-cash financing activity:
Fair value of earn-out liability	20,413		0
Fair value of private placement and public warrants liability	22,932		0
Reclassification of loan and security agreement warrants to equity	6,370		0
Settlement of the first tranche of forward contract	3,305		0
Capitalization of deferred costs to equity upon share issuance	848		0
Purchases of property and equipment recorded in accounts payable	$ 428		$ 664
[1]For discussion on the restatement adjustments, see Note 1 — Description of Business — Restatement of Condensed Consolidated Financial Statements and Immaterial Correction of Prior-Period Errors

Description of Business

Description of Business	6 Months Ended
	Jun. 30, 2022
Description of Business	1. DESCRIPTION OF BUSINESS Rigetti Computing Inc. and its subsidiaries (collectively, the “Company” or “Rigetti”), builds quantum computers and the superconducting quantum processors that power them. Through the Company’s Quantum Computing as a Service (“QCaaS”) platform, the Company’s machines can be integrated into any public, private or hybrid cloud. The Company offers product types of Platform, Research and Software Tools usage in application areas of benchmarking, chemical simulation, education/entertainment, machine learning, and optimization. The Company is located and headquartered in Berkeley, California. The Company also operates in Fremont, California, London, United Kingdom, Adelaide, Australia, British Columbia, Canada and Munich, Germany. The Company’s revenue is derived primarily from operations in the United States and the United Kingdom. Basis of Presentation On March 2, 2022 (the “Closing Date”), a merger transaction between Rigetti Holdings, Inc. (“Legacy Rigetti”) and Supernova Partners Acquisition Company II, Ltd. (“SNII”) was completed (the “Business Combination”, see Note 3). In connection with the closing of the Business Combination, the Company changed its name to Rigetti Computing, Inc. and all of SNII Class A ordinary shares and SNII Class B ordinary shares automatically converted into shares of common stock, par value $0.0001, of the Company (the “Common Stock”) on a one-for-one The Company determined that Legacy Rigetti was the accounting acquirer in the Business Combination based on an analysis of the criteria outlined in Accounting Standards Codification (ASC) 805, Business Combination. The determination was primarily based on the following facts: • Former Legacy Rigetti stockholders have a controlling voting interest in the Company; • The Company’s board of directors as of immediately after the closing is comprised of eight board members, six seats occupied by previous Rigetti board members and one seat being occupied by a previous Supernova representative. The final eighth seat was filled by an individual who did not have ties to either Rigetti or Supernova pre-merger; • Legacy Rigetti management continues to hold executive management roles for the post-combination company and be responsible for the day-to-day Accordingly, for accounting purposes, the Business Combination was treated as the equivalent of Legacy Rigetti issuing stock for the net assets of SNII, accompanied by a recapitalization. The primary asset acquired from SNII was related to the cash amounts that was assumed at historical costs. Separately, the Company also assumed warrants that were deemed to be derivatives and meet liability classification subject to fair value adjustment measurements upon closing of the Business Combination (the “Closing”). No goodwill or other intangible assets were recorded as a result of the Business Combination. While SNII was the legal acquirer in the Business Combination, because Legacy Rigetti was deemed the accounting acquirer, the historical financial statements of Legacy Rigetti became the historical financial statements of the combined company, upon the consummation of the Business Combination. As a result, the financial statements included in this report reflect (i) the historical operating results of Legacy Rigetti prior to the Business Combination; (ii) the combined results of SNII and Legacy Rigetti following the closing of the Business Combination; (iii) the assets and liabilities of Legacy Rigetti at their historical cost; and (iv) the Company’s equity structure for all periods presented. The equity structure has been retroactively restated in all comparative periods up to the Closing Date, to reflect the number of shares of the Company’s common stock, $0.0001 par value per share, issued to Legacy Rigetti shareholders and Legacy Rigetti convertible preferred shareholders in connection with the Business Combination. As such, the shares and corresponding capital amounts and earnings per share related to Legacy Rigetti redeemable convertible preferred stock and Legacy Rigetti common stock prior to the Business Combination have been retroactively restated as shares reflecting the exchange ratio established in the Business Combination. The accompanying unaudited condensed consolidated financial statements of the Company and its subsidiaries have been prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”) and applicable rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) regarding interim financial reporting. All intercompany transactions and balances have been eliminated in consolidation. All dollar amounts, except share and per share amounts, in the notes are presented in thousands, unless otherwise specified. The condensed consolidated balance sheet as of December 31, 2021, included herein, was derived from the audited consolidated financial statements as of that date, but does not include all disclosures including certain notes required by U.S. GAAP on an annual reporting basis. Certain information and note disclosures normally included in the consolidated financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. The interim results are not necessarily indicative of the results for any future interim period or for the entire year. Therefore, these unaudited condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements and notes included as Exhibit 99.1 to the Company’s Current Report on Form 8-K, Risks and Uncertainties — COVID-19— COVID-19. COVID-19 COVID-19 Change in Fiscal Year — year-end year-end Restatement of Condensed Consolidated Financial Statements and Immaterial Correction of Prior-Period Errors On November 14, 2022, the audit committee of the Company’s board of directors (the “Audit Committee” ), based on the recommendation of, and after consultation with, the Company’s management, concluded that the Company’s previously issued unaudited interim condensed consolidated financial statements for the quarters ended March 31, 2022 and June 30, 2022 (the “Affected Financials”), as previously filed with the SEC, should no longer be relied upon and should be restated due to the matters described below. The unaudited condensed consolidated financial statements for the quarter ended June 30, 2022 are restated in this Quarterly Report on Form 10-Q/A, 10-Q Earn-out At the closing of the Company’s business combination with Supernova Partners Acquisition Company II Ltd. on March 2, 2022 (the “Closing”), (i) 2,479,000 shares of the Company’s “Common Stock, held by Supernova Partners II LLC (the “SPAC Sponsor”) (such shares, the “Promote Sponsor Vesting Shares”) became subject to vesting and are considered unvested and will only vest if, during the five year period following the Closing, the volume weighted average price of the Common Stock equals or exceeds $12.50 for any twenty trading days thirty consecutive trading days twenty trading days thirty consecutive trading days The Sponsor Vesting Shares are accounted for as liability classified instruments because the earn-out earn-out earn-out earn-out The Company assessed the materiality of the error, both quantitatively and qualitatively, in accordance with the SEC’s Staff Accounting Bulletin No. 99, and concluded that the error is material to the Affected Financials based upon quantitative aspects of the error. The revised weighting used for the volatility assumption in the estimation of the fair value of the Sponsor Vesting Shares had the following impact on the unaudited condensed consolidated financial statements of the Company for the three and six months ended June 30, 2022 included in the Affected Financials: • a decrease in the Earn-out • a decrease in the gain from Change in the Fair Value of Earn-out • an increase in Net Loss and Net Loss per Share recorded in the unaudited condensed consolidated statement of operations for the period ended June 30, 2022 included in the Affected Financials; and • a decrease in the Change in the Fair value of Earn-out non-cash Earn-out Private Warrant Valuation Prior to the Business Combination, SNII issued 4,450,000 private placement warrants (“Private Warrants”). Each whole warrant entitles the holder to purchase one share of the Company’s Common Stock at a price of $11.50 per share, subject to adjustments and will expire five years after the Business Combination or earlier upon redemption or liquidation. The Company reassessed the calculations of fair value for its Private Warrants that are treated as derivative warrant liabilities for the periods ended March 31, 2022 and June 30, 2022. As part of the Company’s accounting for the derivative warrant liability related to the Private Warrants in connection with the preparation of the financial statements for the three months ended September 30, 2022, the Company evaluated the valuation assumptions used in estimating the fair value of the Private Warrants. During this evaluation, it was determined that the calculated volatility used in the valuation of the derivative warrant liability related to the Private Warrants was based on the assumption that such warrants were not subject to redemption at $10 per share but were subject to redemption at $18 per share. The Private Warrants, however, are not redeemable at either of these prices as long as the warrants are held by either the Sponsor or its permitted transferees. During the first two quarters of the 2022 fiscal year, the Private Warrants were held by the Sponsor; therefore, the Private Warrants were not redeemable at either price during such periods. The Company revised this assumption in the calculation of the volatility of the Private Warrants, which impacted the valuation of the liability related to the Private Warrants included in the Affected Financials. The Company assessed the materiality of the error, both quantitatively and qualitatively, in accordance with the SEC’s Staff Accounting Bulletin No. 99, and concluded that the error is material to the Affected Financials based upon quantitative aspects of the error. The revised assumption used for the calculation of the volatility in the estimation of the fair value of the Private Warrants had the following impact on the unaudited condensed consolidated financial statements of the Company for the three and six months ended June 30, 2022 included in the Affected Financials: • an increase in the Derivative Warrant Liabilities recorded on the unaudited condensed consolidated balance sheet as of June 30, 2022 included in the Affected Financials; • an increase in the gain from the Change in the Fair Value of Derivative Warrant Liabilities for the three months ended June 30, 2022 and a decrease in the gain from the Change in the Fair Value of Derivative Warrant Liabilities for the six months ended June 30, 2022 included in the Affected Financials; • a decrease in Net Loss and Net Loss per Share for the three months ended June 30, 2022 and an increase in Net Loss and Net Loss per Share for the six months ended June 30,2022 included in the Affected Financials; and • a decrease in the Change in Fair value of Derivatives Liability recorded in the unaudited condensed consolidated statements of cash flows as supplemental disclosure of non-cash Additional Operating Expenses In addition, in connection with the preparation of the financial statements for the three months ended September 30, 2022, the Company completed its analysis with respect to the treatment of additional operating expenses relating to electrical utility fees for a portion of the electrical usage at its Berkeley location since 2019 that were not paid and recognized in prior periods. The Company has cumulatively recorded an accrual of $1.6 million as of June 30, 2022, which includes an accrual of $1.5 million recorded for the three months ended March 31, 2022, reflecting an out-of-period Trinity Warrant Valuation As part of the restatement of the financial statements for the quarters ended March 31, 2022 and June 30, 2022, the Company also recorded the correction of an immaterial error related to the valuation of the liability associated with the warrants issued to Trinity Capital Inc. in the restated financial statements for the quarter ended March 31, 2022, and reversed the out-of-period The Company recorded the following adjustments to correct the prior period errors in the financial statements as of and for the period ended June 30, 2022 such that the consolidated balance sheet and the year-to-date Restated Condensed Consolidated Balance Sheet (unaudited) As of June 30, 2022 As reported As adjusted - (a) As adjusted - (b) As adjusted - (c) As adjusted - (d) As adjusted - Total As restated Accrued expenses and other current liabilities $ 4,428 $ — $ 1,590 $ — $ — $ 1,590 $ 6,018 Total current liabilities 11,279 — 1,590 — — 1,590 12,869 Derivative warrant liabilities 8,944 — — — 3,204 3,204 12,148 Earn-out 8,925 (1,069 ) — — (1,069 ) 7,856 Total liabilities 54,765 (1,069 ) 1,590 — 3,204 3,725 58,490 Additional paid-in 401,290 6,170 — — (445 ) 5,725 407,015 Accumulated deficit (227,575 ) (5,101 ) (1,590 ) — (2,759 ) (9,450 ) (237,025 ) Total stockholders’ equity (deficit) 173,825 1,069 (1,590 ) — (3,204 ) (3,725 ) 170,100 Restated Condensed Consolidated Statements of Operations (unaudited) For the Three Months Ended June 30, 2022 As reported As adjusted - (a) As adjusted - (b) As adjusted - (c) As adjusted - (d) As adjusted - Total As restated Research and development $ 12,634 $ — $ 113 $ — $ — $ 113 $ 12,747 Total operating expenses 26,906 — 113 — — 113 27,019 Loss from operations (25,645 ) — (113 ) — — (113 ) (25,758 ) Change in fair value of derivate warrant liabilities 8,687 — — (1,331 ) 624 (707 ) 7,980 Change in fair value of earn-out 8,024 (1,458 ) — — — (1,458 ) 6,566 Total other income (expense), net 15,671 (1,458 ) — (1,331 ) 624 (2,165 ) 13,506 Net loss $ (9,974 ) $ (1,458 ) $ (113 ) $ (1,331 ) $ 624 $ (2,278 ) $ (12,252 ) Net loss per share attributed to common stockholders - basic and diluted $ (0.09 ) $ (0.02 ) $ (0.11 ) For the Six Months Ended June 30, 2022 As reported As adjusted - (a) As adjusted - (b) As adjusted - (c) As adjusted - (d) As adjusted - Total As restated Research and development $ 25,083 $ — $ 1,590 $ — $ — $ 1,590 $ 26,673 Total operating expenses 52,391 — 1,590 — — 1,590 53,981 Loss from operations (49,440 ) — (1,590 ) — — (1,590 ) (51,030 ) Change in fair value of derivate warrant liabilities 14,509 — — — (2,759 ) (2,759 ) 11,750 Change in fair value of earn-out 17,658 (5,101 ) — — (5,101 ) 12,557 Total other income (expense), net 28,996 (5,101 ) — — (2,759 ) (7,860 ) 21,136 Net loss $ (20,444 ) $ (5,101 ) $ (1,590 ) $ — $ (2,759 ) $ (9,450 ) $ (29,894 ) Net loss per share attributed to common stockholders - basic and diluted $ (0.24 ) $ (0.12 ) $ (0.36 ) Restated Condensed Consolidated Statement of Redeemable Convertible Preferred Stock and Stockholder’s (Deficit) Equity (unaudited) as of June 30, 2022 For the Six Months Ended As reported As adjusted - (a) As adjusted - (b) As adjusted - (c) As adjusted - (d) As adjusted - Total As Restated Additional Paid-In $ 401,290 $ 6,170 $ — $ — $ (445 ) $ 5,725 $ 407,015 Accumulated deficit (227,575 ) (5,101 ) (1,590 ) — (2,759 ) (9,450 ) (237,025 ) Total Stockholders’ (Deficit) Equity 173,825 1,069 (1,590 ) — (3,204 ) (3,725 ) 170,100 Restated Condensed Consolidated Statement of Cash Flows (unaudited) For the Six Months Ended As reported As adjusted - (a) As adjusted - (b) As adjusted - (c) As adjusted - (d) As adjusted - Total As restated Net loss $ (20,444 ) $ (5,101 ) $ (1,590 ) $ — $ (2,759 ) $ (9,450 ) $ (29,894 ) Accrued expenses and other current liabilities 967 — 1,590 — — 1,590 2,557 Change in fair value of derivative warrant liabilities (14,509 ) — — — 2,759 2,759 (11,750 ) Change in fair value of earnout liability (17,658 ) 5,101 — — — 5,101 (12,557 ) Net cash used in operating activities (35,085 ) — — — — — (35,085 ) The cumulative impact of the error correction s accumulated deficit million, and the impact on stockholders’ equity (deficit) was million as of and for the period ended June 30, 2022. The impact on net loss was million for the three months ended June 30, 2022. The cumulative impact of the error correction on the Company’s net loss for the six months ended June 30, 2022 was $9.5 million. There was no impact to net cash used in operating activities for the six months ended June 30, 2022.

Summary of Significant Accounti

Summary of Significant Accounting Policies	6 Months Ended
	Jun. 30, 2022
Summary of Significant Accounting Policies	2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Emerging Growth Company — The Company anticipates that it will remain an EGC under the JOBS Act until the earliest of (a) the last day of Rigetti’s first fiscal year following the fifth anniversary of the completion of SNII’s initial public offering, (b) the last date of Rigetti’s fiscal year in which Rigetti has total annual gross revenue of at least $1.07 billion, (c) the date on which Rigetti is deemed to be a “large accelerated filer” under the rules of the SEC with at least $700.0 million of outstanding securities held by non-affiliates non-convertible Use of Estimates — Reclassifications — Deferred Offering Costs — paid-in The Company incurred $0.8 million and $0 of offering costs for both the three and six months ended June 30, 2022 and 2021, respectively, which related to filing new registration statements with the SEC after the close of the Business Combination. These costs are incremental to those disclosed in Note 3. As the shares for which the registration statements were filed were issued as of June 30, 2022, the Company recorded the costs as a reduction to additional paid-in Deferred Financing Costs — Segments — Foreign Currency — Comprehensive Loss — non-owner Cash and Restricted Cash — As of December 31, 2021, restricted cash consists of cash secured as collateral for letters of credit in favor of the Company’s landlord and its corporate credit card program. The following table provides a reconciliation of cash and restricted cash in the consolidated balance sheets to the total amount shown in the consolidated statements of cash flows for the six months ended June 30, 2022: (In thousands) June 30, December 31, Cash $ 184,020 $ 11,729 Restricted cash 117 317 Total cash and restricted cash $ 184,137 $ 12,046 Accounts Receivable — write-offs, Public and Private Warrants — The Private Warrants do not meet the derivative scope exception and are accounted for as derivative liabilities. Specifically, the Private Warrants contain provisions that cause the settlement amounts to be dependent upon the characteristics of the holder of the warrant which is not an input into the pricing of a fixed-for-fixed Subsequent to the separate listing and trading of the Public Warrants the fair value of the Public Warrants has been measured based on the observable listed prices for such warrants and the fair value of the Private Warrants are measured using an option pricing model. On the consummation of the Business Combination, the Company recorded a liability related to the Private Warrants of $9.6 million (as restated and discussed in Note 1), with an offsetting entry to additional paid-in Similarly, on consummation of the Business Combination, the Company recorded a liability related to the Public Warrants of $16.3 million, with an offsetting entry to additional paid-in Derivative Warrant Liabilities — Other than the Public and Private Warrants noted above, the Company also has other warrants issued and outstanding which are recognized as derivative liabilities in accordance with ASC 815. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjusts the instruments to fair value at each reporting period until exercised. The fair value of the warrant liabilities issued were initially measured using the Black- Scholes model and will be subsequently remeasured at each reporting period with changes recorded as a component of other income in the Company’s consolidated statement of operations. Derivative warrant liabilities are classified as non-current Earn-Out “Earn-Out These Sponsor Vesting Shares are accounted for as liability classified instruments because the Earn-Out As of June 30, 2022, the Earn-Out Significant inputs into the respective models at the March 2, 2022 (the initial recognition) and June 30, 2022 are as follows: Valuation Assumptions Initial Recognition June 30, 2022 As Restated (1) As Restated (1) Stock Price $ 9.43 $ 3.67 Simulated trading days 1,198.00 1,177.00 Volatility (annual) (1) 30.50 % 79.20 % Risk-free rate 1.74 % 2.98 % Estimated time to expiration (years) 5 4.67 (1) As restated and discussed in Note 1 — Description of Business — Restatement of Condensed Consolidated Financial Statements and Immaterial Correction of Prior-Period Errors Revenue Recognition — Development contracts are generally multi-year, non-recurring When the Company’s contracts with customers contain multiple performance obligations, the transaction price is allocated on a relative standalone selling price basis to each performance obligation. The Company typically determines standalone selling price based on observable selling prices of our products and services. In instances where standalone selling price is not directly observable, standalone selling price is determined using information that may include market conditions and other observable inputs. Standalone selling price is typically established as a range. In situations in which the stated contract price for a performance obligation is outside of the applicable standalone selling price range and has a different pattern of transfer to the customer than the other performance obligations in the contract, the Company will reallocate the total transaction price to each performance obligation based on the relative standalone selling price of each. The transaction price is the amount of consideration to which the Company expects to be entitled in exchange for transferring goods and services to the customer. Revenue is recorded based on the transaction price, which includes fixed consideration and estimates of variable consideration. The amount of variable consideration included in the transaction price is constrained and is included only to the extent it is probable that a significant reversal of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is subsequently resolved. Net income (loss) per share — C-1 if-converted Stock-Based Compensation — 4-year change-in-control Compensation expenses are based on the grant-date fair value of the awards and recognized over the requisite service period using a straight-line method for stock options and RSUs granted under the 2022 Plan. Compensation expense for RSUs granted under the 2013 Plan are recognized using a graded vesting method. Compensation expense for RSAs are recognized fully on grant date. The Company has elected to account for forfeitures of employee stock awards as they occur. Concentrations of Credit Risk — Significant customers that represent 10% or more of revenue are set forth in the following tables: For the Six Months Ended June 30, Customer 2022 2021 Customer A 33 % * Customer B 28 % 25 % Customer C 16 % 30 % Customer D 10 % * Customer E * 36 % For the Three Months Ended June 30, Customer 2022 2021 Customer A 32 % 30 % Customer B 22 % 64 % Customer C 19 % * Customer D 19 % * * Customer accounted for less than 10% of revenue in the respective period Significant customers that represent 10% or more of accounts receivable are set forth in the following tables: Customer June 30, December 31, 2022 2021 Customer A 25 % 35 % Customer B 24 % 34 % Customer C 16 % 29 % Customer D 16 % * Customer E 11 % * * Customer accounted for less than 10% of accounts receivable in the respective period For the three and six months ended June 30, 2022, sales to government entities comprised 67.8% and 72.0% of the Company’s total revenue, respectively. For the three and six months ended June 30, 2021, sales to government entities comprised 69.7% and 74.9% of the Company’s total revenue, respectively. Recently Issued Accounting Pronouncements — 2022-03, In February 2016, the FASB issued ASU 2016-02, 2016-02 2018-01, ASU2018-10, 2018-20 2019-01, 2016-02). 2016-02 right-of-use 2016-02 2016-02 2016-02, No other new accounting pronouncement recently issued or newly effective had or is expected to have a material impact on the condensed consolidated financial statements.

Business Combination

Business Combination	6 Months Ended
	Jun. 30, 2022
Business Combinations [Abstract]
Business Combination	3. BUSINESS COMBINATION As discussed in Note 1, on March 2, 2022, the Business Combination was completed. Pursuant to the Company’s certificate of incorporation, as amended on March 2, 2022, the Company is authorized to issue 1,000,000,000 shares of Common Stock and 10,000,000 shares of preferred stock, par value $0.0001, of the Company (the “Preferred Stock”). The holders of shares of Common Stock are entitled to one non-voting. No On March 1, 2022, prior to the Closing, as contemplated by the Merger Agreement and following approval by SNII’s shareholders at an extraordinary general meeting of shareholders held on February 28, 2022 (the “Extraordinary General Meeting”), SNII filed a notice of deregistration with the Cayman Islands Registrar of Companies, together with the necessary accompanying documents, and filed a certificate of incorporation (the “Certificate of Incorporation”) and a certificate of corporate domestication with the Secretary of State of the State of Delaware, under which SNII was domesticated and continues as a Delaware corporation, changing its name to “Rigetti Computing, Inc.” As a result of and upon the effective time of the Domestication (which occurred on March 1, 2022), among other things:(1) each then issued and outstanding Class A ordinary share, par value $0.0001 per share, of SNII (“SNII Class A ordinary share”) converted automatically, on a one-for-one one-for-one one-fourth Immediately prior to the effective time of the Business Combination, each share of Legacy Rigetti’s Series C preferred stock and Series C-1 As a result of the Business Combination, among other things (1) all outstanding shares of Legacy Rigetti Common Stock as of immediately prior to the Closing (including Legacy Rigetti Common Stock resulting from the Legacy Rigetti Preferred Stock Conversion), were exchanged at an exchange ratio of 0.7870 (the “Exchange Ratio”) for an aggregate of 78,959,579 shares of Common Stock; (2) each warrant to purchase Legacy Rigetti Common Stock converted into a warrant to purchase shares of Common Stock (“Assumed Warrant”), with each Assumed Warrant subject to the same terms and conditions as were applicable to the original Legacy Rigetti warrant and having an exercise price and number of shares of Common Stock purchasable based on the Exchange Ratio and other terms contained in the Merger Agreement; (3) each option to purchase Legacy Rigetti Common Stock converted into an option to purchase shares of Common Stock (“Assumed Option”), with each Assumed Option subject to the same terms and conditions as were applicable to the original Legacy Rigetti option and with an exercise price and number of shares of Common Stock purchasable based on the Exchange Ratio and other terms contained in the Merger Agreement, and; (4) each Legacy Rigetti restricted stock unit award converted into a restricted stock unit award to receive shares of Common Stock (“Assumed RSU Award”), with each Assumed RSU Award subject to the same terms and conditions as were applicable to the Legacy Rigetti restricted stock unit award, and with the number of shares of Common Stock to which the Assumed RSU Award converted based on the Exchange Ratio and other terms contained in the Merger Agreement. In connection with the execution of the Merger Agreement, SNII entered into a sponsor support agreement (the “Sponsor Support Agreement”) with the Sponsor, Legacy Rigetti and SNII’s directors and officers. Pursuant to the Sponsor Support Agreement, the Sponsor and SNII’s directors and officers (“Sponsor Holders”), among other things, agreed to vote all of their shares of SNII capital stock in favor of the approval of the Business Combination. In addition, pursuant to the Sponsor Support Agreement, (i) 2,479,000 shares of Common Stock held by the Sponsor Holders became unvested and subject to forfeiture as of the Closing and will only vest if, during the five year period following the Closing, the volume weighted average price of Common Stock equals or exceeds $12.50 for any twenty trading days thirty consecutive trading days twenty trading days thirty consecutive trading days Earn-Out Concurrently with the execution of the Merger Agreement, SNII entered into Subscription Agreements (the “Initial Subscription Agreements”) with certain investors (together, the “Initial PIPE Investors”), pursuant to which the Initial PIPE Investors agreed to subscribe for and purchase, and SNII agreed to issue and sell to the Initial PIPE Investors, an aggregate of 10,251,000 shares of Common Stock at a price of $10.00 per share, for aggregate gross proceeds of $102.5 Million (the “Initial PIPE Financing”). On December 23, 2021, SNII entered into Subscription Agreements (the “Subsequent Subscription Agreements”, and together with the Initial Subscription Agreements, the “Subscription Agreements”) with two “accredited investors” (as such term is defined in Rule 501 of Regulation D) (the “Subsequent PIPE Investors”, and together with the Initial PIPE Investors, the “PIPE Investors”) pursuant to which the Subsequent PIPE Investors agreed to subscribe for and purchase, and SNII agreed to issue and sell to the Subsequent PIPE Investors, an aggregate of 4,390,244 shares of Common Stock at a price of $10.25 per share, for aggregate gross proceeds of $45.0 Million (the “Subsequent PIPE Financing”, and together with the Initial PIPE Financing, the “PIPE Financing”). Pursuant to the Subscription Agreements, Rigetti agreed to provide the PIPE Investors with certain registration rights with respect to the shares purchased as part of the PIPE Financing. The PIPE Financing was consummated immediately prior to the Merger. The Business Combination is accounted for as a reverse recapitalization in accordance with U.S. GAAP. Under this method of accounting, SNII was treated as the “acquired” company for financial reporting purposes. In accounting for the Business Combination and after redemptions, net proceeds received by the Company totaled $225.6 million. The table below shows the net proceeds from business combination and PIPE financing (in thousands): Amount (in thousands) Cash - SNII trust and cash (net of redemption) $ 77,769 Cash - PIPE 147,510 Cash - SNII operating account 325 Net Proceeds from Business Combination and PIPE $ 225,604 Transaction costs consist of direct legal, accounting and other fees relating to the consummation of the Merger. Legacy Rigetti transaction costs specific and directly attributable to the business combination totaled $20.65 million. These costs were initially capitalized as incurred in deferred offering assets on the consolidated balance sheets. Upon the Closing, transaction costs related to the issuance of shares were recognized in stockholders’ equity (deficit) while costs associated with the Public Warrants, Private Warrants and Sponsor Vesting Shares were expensed in the consolidated statements of operations. Of the total transaction cost of $20.65 million, $19.75 million was recorded to additional paid-in 2022. For the six months ended June 30, 2022, the Company also paid a one-time The amount recorded to additional paid-in-capital earn-out The number of shares of common stock issued immediately following the consummation of the Business Combination was as follows: Common Stock—SNII Class A, outstanding prior to Business Combination 34,500,000 Less: redemption of SNII Class A ordinary shares (22,915,538 ) Common Stock—SNII Class A ordinary shares 11,584,462 Common Stock—SNII Class B ordinary shares* 8,625,000 Shares issued in PIPE 14,641,244 Business Combination and PIPE shares 34,850,706 Common stock—Legacy Rigetti** 18,221,069 Common stock—exercise of Legacy Rigetti stock options immediately prior to the closing** 1,123,539 Common stock—exercise of Legacy Rigetti warrants immediately prior to the closing** 2,234,408 Common stock—upon conversion of Legacy Rigetti Series C preferred stock** 54,478,261 Common stock—upon conversion of Legacy Rigetti Series C-1 2,902,302 Total shares of common stock immediately after Business Combination 113,810,285 * Includes (i) 2,479,000 shares of Common Stock held by the Sponsor (the “Promote Sponsor Vesting Shares”) and (ii) 580,273 shares of Common Stock held by the Sponsor (“Sponsor Redemption-Based Vesting Shares”). ** (i) all outstanding shares of Legacy Rigetti Common Stock as of immediately prior to the Closing (including Legacy Rigetti Common Stock resulting from the Legacy Rigetti Preferred Stock Conversion), were exchanged at an exchange ratio of 0.7870 (the “Exchange Ratio”). (ii) the conversion ratio to Legacy Rigetti Common Stock for the Legacy Series C Preferred Stock was one-for-one eight-for-one.

Revenue Recognition

Revenue Recognition	6 Months Ended
	Jun. 30, 2022
Disaggregation of Revenue [Line Items]
Revenue Recognition	4. REVENUE RECOGNITION The following tables depict the disaggregation of revenue according to the type of good or service and timing of transfer of goods or services for the three and six months ended June 30, 2022 and June 30, 2021: Three Months Ended Three Months Ended Six Months Ended Six Months Ended June 30, June 30, June 30, June 30, 2022 2021 2022 2021 (In thousands) (In thousands) Type of Goods or Service Collaborative research and other professional services $ 1,477 $ 944 $ 2,992 $ 2,547 Access to quantum computing systems 657 596 1,246 1,353 $ 2,134 $ 1,540 $ 4,238 $ 3,900 Timing of Revenue Recognition Revenue recognized at a point in time $ — $ — $ — $ — Revenue recognized over time 2,134 1,540 4,238 3,900 $ 2,134 $ 1,540 $ 4,238 $ 3,900 Selected condensed consolidated balance sheet line items that reflect accounts receivable, contract assets and liabilities as of June 30, 2022 and December 31, 2021 were as follows: June 30, December 31, 2022 2021 (In thousands) Trade receivables $ 2,350 $ 961 Unbilled receivables $ 222 $ 582 Deferred revenue $ (1,108 ) $ (985 ) Changes in deferred revenue from contracts with customers were as follows: Six Months Ended 2022 (In thousands) Balance at beginning of period $ (985 ) Deferral of revenue (673 ) Recognition of deferred revenue 550 Balance at end of period $ (1,108 ) Remaining performance obligations represent the portion of the transaction price that has not yet been satisfied or achieved. As of June 30, 2022, the aggregate amount of the transaction price allocated to remaining performance obligations was approximately $9.5 million. The Company expects to recognize estimated revenues related to performance obligations that are unsatisfied (or partially satisfied) in the amounts of approximately $3.8 million during the remainder of the year ended December 31, 2022, and $5.7 million during the years ended December 31, 2023 and December 31, 2024. Deferred Contract Acquisition and Fulfillment Costs—The Company has not identified any costs that are incremental to the acquisition of customer contracts that would be capitalized as deferred costs on the balance sheet in accordance with ASC 340-40. 340-40

Commitments and Contingencies

Commitments and Contingencies	6 Months Ended
	Jun. 30, 2022
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	5. COMMITMENTS AND CONTINGENCIES Leases — The Company leases office spaces under noncancelable operating lease agreements, which expire through 2029. The Company is required to pay property taxes, insurance, and normal maintenance costs for certain of these facilities and will be required to pay any increases over the base year of these expenses on the remainder of the Company’s facilities. The Company recognizes rent expense on a straight-line basis over the lease term. Rent expense for operating leases for the three months ended June 30, 2022 and 2021 was $0.5 million and $0.4 million, respectively. Rent expense for operating leases for the six months ended June 30, 2022 and 2021 was $1.0 million and $0.8 million, respectively. The Company has accrued $0.4 million in deferred rent as of June 30, 2022 and December 31, 2021, respectively, primarily relating to one of its office spaces. Deferred rent that will be recognized within the 12 months after the balance sheet date is included within accrued expenses and other current liabilities, the remaining balance is recorded within other liabilities on the Company’s consolidated balance sheets. Future minimum lease payments under non-cancelable As of June 30, 2022 (in thousands) Remainder of 2022 $ 879 2023 1,262 2024 1,299 2025 1,338 2026 1,379 Thereafter 4,006 Total minimum future lease payments $ 10,163 Litigation — The Company is periodically involved in legal proceedings, legal actions and claims arising in the normal course of business. Management believes that the outcome of such legal proceedings, legal actions and claims will not have a significant adverse effect on the Company’s financial position, results of operations or cash flows.

Financing Arrangements

Financing Arrangements	6 Months Ended
	Jun. 30, 2022
Financing Arrangements	6. FINANCING ARRANGEMENTS Loan and Security Agreement In March 2021, the Company entered into an agreement (the “Loan Agreement”) with Trinity Capital Inc. (“Trinity”) to secure a debt commitment of $12.0 million (the “Tranche A”) which was drawn at the closing. The term loan is collateralized by a first-priority, senior secured interest in substantially all of the Company’s assets. In conjunction with the Loan Agreement, the Company issued Trinity a warrant to purchase shares of common stock (the “Trinity Warrants”) which is recorded at fair value using the Black-Scholes model, see Note 9 for the fair value assumptions. The Loan Agreement contains customary representations, warranties and covenants; however, the debt agreement does not include any financial covenants. In May 2021, the debt agreement was modified to increase the overall debt commitment by $15.0 million (the “Tranche B” or the “Amendment”) and $8.0 million of the additional commitment was drawn at the closing and the remaining commitment of $7.0 million was available at the Company’s option at any time through March 10, 2022 subject to certain conditions. The Company drew the $7.0 million in November 2021. In conjunction with the Amendment, the Company cancelled the Initial Warrants and issued 995,099 (783,129 shares post conversion upon the closing of the Business Combination) warrant shares to purchase the common stock which was an incremental cost allocated between Tranche A and Tranche B, see Note 9 for further information on these warrants. The Amendment to the debt agreement was considered a modification for accounting purposes. The Company capitalized $2.8 million of debt issuance costs which consist of incremental costs incurred for the lenders and third-party Under the Amendment, the maturity date was modified to be the date equal to 48 months from the first payment date of each specific cash advance. Subject to an interest only period of 19 months following each specific cash advance date, the term loan incurs interest at a rate of the of greater of 11% and the US Prime Rate plus 7.50% per annum, payable monthly. The Term Loan includes certain negative covenants, primarily consisting of restrictions on the Company’s ability to incur indebtedness, pay dividends, execute fundamental change transactions, and other specified actions. In addition, the Company is required to pay a final payment fee equal to 2.75% of the aggregate amount of all term loan advances. The final payment fee is being accreted and amortized into interest expense using the effective interest rate method over the term of the loan. The effective interest was between 17.83 – 23.70% for all tranches of the debt as of June 30, 2022. In January 2022, the debt agreement was modified to increase the overall debt commitment by $5.0 million (the “Tranche C” or the “Third Amendment”) which was drawn on January 27, 2022. Subject to an interest only period of 19 months, Tranche C incurs interest at a rate of the greater of 11% and the US Prime Rate plus 7.50% per annum, payable monthly, until the maturity date, February 1, 2026. Other modifications per the amendment included an extension of the requirement to raise an additional $75 million of equity and a defined exit fee for the additional $5.0 million to be at 20% of the advanced funds under the amendment. The Company paid an exit fee of $1.0 million which is 20% of the Tranche C amount upon the consummation of a merger. The exit fee is not applicable to Tranche A and Tranche B. In conjunction with the amendment, the Company also guaranteed payment of all monetary amounts owed and performance of all covenants, obligations and liabilities. The book value of debt approximates its fair value given its maturity and variable interest rate. Long term debt and the unamortized discount balances are as follows (in thousands): June 30, December 31, 2022 2021 (in thousands) Outstanding principal amount $ 32,000 $ 27,000 Add: accreted liability of final payment fee 256 125 Less: unamortized debt discount, long term (2,117 ) (1,618 ) Less: current portion of long term debt-principal (4,938 ) (1,291 ) Debt-net of current portion $ 25,201 $ 24,216 Current portion of long term debt - principal $ 4,938 $ 1,291 Less: current portion of unamortized debt discount (712 ) (716 ) Debt-current portion $ 4,226 $ 575 For the three and six months ended June 30, 2022, the Company has recorded interest expense of $1.2 million and $2.4 million, which includes the accretion of the end of term liability of $88.9 thousand and $134.8 thousand, the amortization of commitment fee asset of $68 thousand and $116.3 thousand and the amortization of debt issuance cost of $179.7 thousand and $415.6 thousand, respectively. The unamortized issuance cost of $2.8 million at June 30, 2022 is offset against the carrying value of the term loan in the accompanying condensed consolidated balance sheet. See Deferred Financing Cost policy at Note 2. Scheduled principal payments on total outstanding debt, as of June 30, 2022, are as follows (in thousands): June 30, December 31, 2022 2021 (in thousnds) 2022 $ 702 $ 702 2023 9,273 8,682 2024 12,914 11,008 2025 8,734 6,608 2026 377 — $ 32,000 $ 27,000

Redeemable Convertible Preferre

Redeemable Convertible Preferred Stock	6 Months Ended
	Jun. 30, 2022
Temporary Equity [Line Items]
Redeemable Convertible Preferred Stock	7. REDEEMABLE CONVERTIBLE PREFERRED STOCK Legacy Rigetti was authorized to issue 73,389,000 shares of Series C preferred stock and 62,537,577 shares of Series C-1

Common Stock

Common Stock	6 Months Ended
	Jun. 30, 2022
Class of Stock [Line Items]
Common Stock	8. COMMON STOCK As discussed in Note 3, on March 2, 2022, the Company consummated a Business Combination which has been accounted for as a reverse capitalization. Pursuant to the certificate of incorporation as amended on March 2, 2022, the Company is authorized to issue 1,000,000,000 shares of Common Stock and 10,000,000 shares of Preferred Stock. The holders of shares of Common Stock are entitled to one vote for each share of common stock held. The Preferred Stock is non-voting. In the event of any voluntary or involuntary liquidation, dissolution or winding up of the Company, and after payment to the holders of shares of Preferred Stock of their liquidation preferences, the holders of the common stock are entitled to the entire remaining assets of the Company on a pro rata basis. As a result of the Business Combination (see Note 3), the Company has retroactively adjusted the warrants and stock-based awards outstanding prior to March 2, 2022 to give effect to the Exchange Ratio used to determine the number of shares of common stock into which they were converted. As of June 30, 2022, the Company has reserved the following shares of common stock for issuance upon the conversion, exercise or vesting of the underlying instruments: Common Stock Common Stock Warrants 18,126,014 Stock-Based Awards - RSUs Outstanding 11,850,526 Stock-Based Awards - Options Outstanding 9,482,711 Total 39,459,251

Warrants

Warrants	6 Months Ended
	Jun. 30, 2022
Class of Warrant or Right [Line Items]
Warrants	9. WARRANTS As a result of the Business Combination (see Note 3), the Company has retroactively adjusted the Rigetti warrants outstanding and corresponding strike price prior to March 2, 2022 to give effect to the Exchange Ratio used to determine the number of shares of common stock into which they were converted. Liability Classified Warrants Public Warrants Each Public Warrant entitles the holder to the right to purchase one share of common stock at an exercise price of $11.50 per share. No fractional shares will be issued upon exercise of the Public Warrants. The Company may elect to redeem the Public Warrants subject to certain conditions, in whole and not in part, at a price of $0.01 per Public Warrant if (i) 30 days’ prior written notice of redemption is provided to the holders, and (ii) the last reported sale price of the Company’s common stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading Private Warrants The Private Warrants may not be redeemed by the Company so long as the Private Warrants are held by the initial purchasers, or such purchasers’ permitted transferees. The Private Warrants have terms and provisions identical to those of the Public Warrants, including as to exercise price, exercisability and exercise period, except if the Private Warrants are held by someone other than the initial purchasers’ permitted transferees, then the Private Warrants are redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants. As of June 30, 2022, there were 4,450,000 Private Warrants issued and outstanding. The fair value of the Private Warrant was measured using the Black Scholes model approach. Significant inputs into the respective models at March 2, 2022 (the initial recognition) and June 30, 2022 are as follows: Valuation Assumptions Initial Recognition on March 2, June 30, 2022 As Restated (1) As Restated (1) Stock Price $ 9.43 $ 3.67 Strike Price $ 11.50 $ 11.50 Volatility (annual) (1) 30.66 % 79.03 % Risk-free rate 1.74 % 3.01 % Estimated time to expiration (years) 5 4.672 Dividend yield — % — % (1) As restated and discussed in Note 1 — Description of Business — Restatement of Condensed Consolidated Financial Statements and Immaterial Correction of Prior-Period Errors Trinity Warrants The Trinity Warrants were issued in March of 2021 for warrants to purchase 313,252 shares of common stock, and additional warrants to purchase 469,877 shares of common stock were issued in connection with the Tranche B Amendment, see Note 6. Therefore, there were total of 783,129 common stock warrants issued in conjunction with the Loan and Security Agreement in 2021. The Company utilized Black-Scholes model to determine grant fair value of the warrants which was approximately $2.7 million which was recorded as part of the Debt Issuance Cost. The outstanding common stock warrants were recognized as liabilities on the consolidated balance sheet and were measured at their inception date fair value using the Black-Scholes model and were subsequently remeasured at each reporting period with change recorded as a component of other income in the Company’s consolidated statement of operations. The warrant liability balance was $6.4 million as of June 2, 2022, at which time all outstanding Trinity Warrants of 783,129 were exercised into shares of the Company’s Common Stock and the warrant liability reclassified to equity upon such exercise. The fair value of the warrant liability of $6.4 million was reclassified to equity upon such exercise. The Company recorded a total loss of $1.5 million and million to Change in Fair Value of Warrant Liability as a component of other income in the condensed consolidated statement of operations for the three and six months ended June 30, 2022, respectively, after applying the revised valuation inputs as described in Note 1. The warrant issued in conjunction with the Loan and Security Agreement is classified as a liability under ASC 480, “Distinguishing Liabilities from Equity”. See Deferred Financing Cost disclosure at Note 2 Summary of Significant Accounting Policies. The fair value of the Trinity Warrant liabilities presented above were measured using the Black Scholes model approach. Significant inputs into the respective models at June 2, 2022, the exercise date of the Trinity Warrants, are as follows: Valuation Assumption - June 2 2022 Stock price $ 8.23 Strike price $ 0.27 Volatility (annual) 105.10 % Risk-free rate 2.94 % Estimated time to expiration (years) 9 Dividend yield — % Equity Classified Warrants Series C Preferred Stock Financing Warrants In conjunction with the Series C Preferred Stock Financing (see Note 7), the Company issued a total of 5,248,183 Warrants to purchase Class A Common Stock to the Series C investors. The Warrants have a $0.01 exercise price per share and have a 10-year Customer Warrants In February 2020, the Company issued a Warrant to purchase 2,680,607 shares of Class A Common Stock to a customer in conjunction with a revenue arrangement (the “Customer Warrant”). The Customer Warrants have a $1.152 exercise price per share and have a 10-year The Company followed the guidance in ASC 718 and ASC 606 for the accounting of non-cash The vesting status of the Customer Warrant is as follows at June 30, 2022 and December 31, 2021: June 30, December 31, Vested Customer warrants 1,072,237 1,072,237 Unvested Customer warrants 1,608,370 1,608,359 2,680,607 2,680,596

Forward Warrant Agreement

Forward Warrant Agreement	6 Months Ended
	Jun. 30, 2022
Temporary Equity [Line Items]
Forward Warrant Agreement	10. FORWARD WARRANT AGREEMENT In connection with the execution of the Merger Agreement in October 2021 (See Note 1), Rigetti entered into a warrant subscription agreement (“Forward Warrant Agreement”) with a strategic partner, Ampere Computing LLC (“Ampere”) for the purchase of a warrant for an aggregate purchase price (including amounts from exercise) of $10.0 million. The Forward Warrant Agreement provides for the issuance of a warrant for the purchase of an aggregate of 1,000,000 shares of Common Stock at an exercise price of $0.0001. The purchase of the warrant was conditioned upon, among other things, the consummation of the Business Combination and the entry into a collaboration agreement between Rigetti and Ampere. The parties entered into the collaboration agreement in January 2022. Ampere was required to pay $5.0 million to Rigetti no later than the later of (i) the Closing and (ii) June 30, 2022. On June 30, 2022, pursuant to the Warrant Subscription Agreement, the Company issued the warrant to Ampere upon receipt of an aggregate of $5.0 million (including the exercise price), and upon such payment and issuance, 500,000 shares of the Company’s common stock vested under the warrant and were immediately exercised by Ampere pursuant to the terms of the warrant. Ampere is required to pay an additional $5.0 million to Rigetti no later than the closing date of the listing of Ampere’s capital stock, provided that if the listing has not occurred by the second anniversary of the warrant subscription agreement, Ampere is not obligated to make the additional payment and the Company is not obligated to issue the warrants. The warrant subscription agreement further provides that the Company will use commercially reasonable efforts to file a registration statement to register the resale of the shares issued or issuable pursuant to the warrant and upon such payment the warrant will vest and be exercisable by Ampere with respect to 500,000 shares of Common Stock pursuant to the terms of the warrant. The Company evaluated the Forward Warrant Agreement as a derivative in conjunction with the guidance of ASC 480, “Distinguishing Liabilities from Equity”. The Company calculated the fair value of the Forward Warrant Agreement by using the Forward Contract Pricing methodology at inception and at the end of June 30, 2022. The fair value of the Forward Warrant Agreement was estimated based on the following key inputs and assumptions 1) Assumed holding period 2) Related risk-free rate and 3) Likelihood of the outcome of the various contingencies outlined below. Based on these inputs and assumption, the Company calculated the fair value of the Forward Warrant Agreement to be a $1.5 million derivative asset and a ($0.2 million) derivative liability at June 30, 2022 and December 31, 2021, respectively. The Company has included the derivative asset as a forward contract asset and the derivative liability separately in other liabilities (current) on the balance sheet line in the accompanying consolidated balance sheets as of June 30, 2022 and December 31, 2021, respectively. The change in fair value is recorded as part of the general and administrative operating activities in the Company’s condensed consolidated statements of operations. The following table represents key valuation assumptions as of the quarter ended June 30, 2022. Key Valuation Assumptions Holding period (in years) 0.000 - 0.628 Risk free rate 0.00% - 2.57% Probability of contingency occurrence 50% - 100% Underlying value per share $3.39 - $3.67 The fair value of the Forward Purchase Agreement was determined prior to vesting and exercise of the 500,000 warrants into shares of Company Common Stock upon Ampere’s payment of $5.0 million on June 30, 2022 using the share value at opening market price on June 30, 2022. The fair value of the unexercised Forward Award Agreement was determined using the market close value on June 30, 2022.

Fair Value Measurements

Fair Value Measurements	6 Months Ended
	Jun. 30, 2022
Fair Value Measurements	11. FAIR VALUE MEASUREMENTS The Company reports all financial assets and liabilities and nonfinancial assets and liabilities that are recognized or disclosed at fair value in the consolidated financial statements on a recurring basis. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The authoritative guidance establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to measurements involving significant unobservable inputs (Level 3 measurements). The three levels of the fair value hierarchy are as follows: Level 1—Inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date. Level 2—Inputs are observable, unadjusted quoted prices in active markets for similar assets or liabilities, unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the related assets or liabilities. Level 3—Inputs are unobservable inputs for the asset or liability. The level in the fair value hierarchy within which a fair value measurement in its entirety falls is based on the lowest-level input that is significant to the fair value measurement in its entirety. The fair value measurements of financial assets and liabilities that are measured at fair value at June 30, 2022 and December 31, 2021 are as follows: June 30, 2022 Level 1 Level 2 Level 3 As Restated (1) (in thousands) Assets: Forward Warrant Agreement $ — $ — $ 1,543 Total Assets $ — $ — $ 1,543 Liabilities: Derivative warrant liability-Private Warrants, as restated (1) — — 6,542 Derivative warrant liability-Public Warrants 5,606 — — Earn-out — 7,856 Total liabilities, as restated (1) $ 5,606 $ — $ 14,398 December 31, 2021 Level 1 Level 2 Level 3 (in thousands) Liabilities: Derivative warrant liability - Trinity Warrants — 4,355 Forward warrant agreement — — 230 Total liabilities $ — $ — $ 4,585 (1) For discussion on the restatement adjustments, see Note 1 — Description of Business — Restatement of Condensed Consolidated Financial Statements and Immaterial Correction of Prior-Period Errors As of June 30, 2022, the Company has recorded the following financial instruments subject to fair value measurements: 1) Derivative warrant liabilities— Public Warrants liability and Private Warrants, 2) Forward Warrant Agreement, and 3) Earn-out liability. The fair value of the Public Warrants has been measured based on the observable listed prices for such warrants, a Level 1 measurement. All other financial instruments are classified as Level 3 liabilities as they all include unobservable inputs. The Private Warrants were initially measured at fair value using a Black Scholes model. The Company estimated the fair value of the Forward Warrant Agreement using a forward analysis with unobservable inputs which included selected risk-free rate and probability outcomes. The Company has further discussed the key aspects of the fair value measurements described above in Notes 9 and 10 to the financial statements. The aggregate fair value of the Sponsor Vesting Shares on the Closing date was estimated using a Monte Carlo simulation model. The Company has further discussed the key aspect of the valuation inputs in Note 2 significant accounting policy for Sponsor Earn-Out As of December 31, 2021, the Company recorded a derivative warrant liability – Trinity Warrants which was fair valued based on a Black-Scholes option model with unobservable inputs which included volatility. The Company estimates the volatility of its ordinary share warrants based on implied volatility from the Company’s traded warrants and from historical volatility of select peer company’s ordinary shares that matches the expected remaining life of the warrants. On June 2, 2022, all outstanding Trinity Warrants were exercised into shares of the Company’s common stock. There have been no changes in fair value measurement techniques (other than the change in valuation assumptions described in Note 1) during the three and six months ended June 30, 2022. There were no transfers between Level 1 or Level 2, or transfers in or out of Level 3 of the fair value hierarchy during the three and six months ended June 30, 2022. A summary of the changes in the fair value of the Company’s Level 3 financial instruments as of June 30, 2022 and December 31, 2021 are as follows: Derivative warrant Derivative warrant Forward Earn-out Liability, (in thousands) Balance - December 31, 2021 $ 4,355 $ — $ 230 $ — Initial measurement on March 2, 2022 upon Business Combination, as restated (Note 3) (1) 9,612 20,413 Change in fair values, as restated (1) 2,015 (3,070 ) (5,078 ) (12,557 ) Extinguishment due to exercise of the warrants (6,370 ) — 3,305 — Balance - June 30, 2022, as restated (1) $ — $ 6,542 $ (1,543 ) $ 7,856 (1) For discussion on the restatement adjustments, see Note 1 — Description of Business — Restatement of Condensed Consolidated Financial Statements and Immaterial Correction of Prior-Period Errors

Equity Plans

Equity Plans	6 Months Ended
	Jun. 30, 2022
Equity Plans	12. EQUITY PLANS 2013 Equity Incentive Plan In 2013, the Company adopted the 2013 Plan which provides for the grant of qualified incentive stock options (“ISO”) and nonqualified stock options (“NSO”), restricted stock, restricted stock units (“RSU”) or other awards to the Company’s employees, officers, directors, advisors, and outside consultants. After the Closing Date and consummation of the Business Combination effective March 2, 2022, no additional awards are being made pursuant to the 2013 Plan. Awards outstanding under the 2013 Plan will continue to be governed by such plan; however, the Company will not grant any further awards under the 2013 Plan. 2022 Equity Incentive Plan In connection with the Business Combination (Note 3), the shareholders approved the Rigetti Computing, Inc. 2022 Equity Incentive Plan (the “2022 Plan”) in February, 2022, which became effective immediately upon the Closing Date. The 2022 Plan provides for the grant of ISOs, NSOs, stock appreciation rights, restricted stock awards (“RSA”), restricted stock unit awards, performance awards and other forms of awards to employees, directors and consultants, including employees and consultants of Company’s affiliates. The aggregate number of shares of common stock reserved for future issuance under the 2022 Plan is 18,332,215 shares. The number of shares reserved for issuance under the 2022 Plan will automatically increase on January 1st of each year for a period of nine years commencing on January 1, 2023 and ending on (and including) January 1, 2032, in an amount equal to 5% of the common stock of all classes outstanding on December 31 of the preceding year; provided, however, that the board of directors of the Company may act prior to January 1st of a given year to provide that the increase for such year will be a lesser number of shares of Common Stock. Stock Options A summary of activity related to stock option is summarized as below (in thousands, except for share and per share data): Number of Options Weighted-Average Exercise Price Weighted-average Aggregate Outstanding – December 31, 2021 11,468,275 $ 0.36 8.1 $ 46,839 Granted — Exercised (1,353,145 ) $ 0.27 7,104 Forfeited and expired (632,419 ) $ 0.27 Outstanding - June 30, 2022 9,482,711 $ 0.35 7.7 $ 31,454 Exercisable - June 30, 2022 5,874,426 $ 0.39 7.7 $ 19,258 The weighted-average grant date fair value of options granted during the six months ended June 30, 2021 was $0.09 per share. No new option grants were issued during the six months ended June 30, 2022. The total intrinsic value of options exercised during the six months ended June 30, 2022 and June 30, 2021 is $7.1 million and $0.5 million, respectively. As of June 30, 2022, there was $1.9 million of unrecognized compensation cost related to non-vested 31 Restricted Stock Units A summary of activity related to RSUs is summarized as below: RSUs Weighted Average Balance at December 31, 2021 5,388,455 Granted 9,885,413 $ 4.89 Vested (2,630,699 ) Forfeited (792,643 ) Balance at June 30, 2022 11,850,526 On March 2, 2022, the performance condition of all outstanding RSUs was met due to the closing of the Business Combination. As a result, the Company recorded a cumulative catch-up Total fair value of the RSUs vested during the six months ending June 30, 2022 and 2021 was $12.9 million and $0 respectively. Stock-based compensation expense related to RSUs granted to employees was $10.7 million and $21.9 million for the three and six months ended June 30, 2022, respectively. Stock-based compensation expense was $0 for the three and six months ended June 30, 2021. As of June 30, 2022, the unrecognized compensation expense related to unvested RSUs was approximately $49.1 million which is expected to be recognized over a weighted- average period of approximately 2.24 years. Restricted Stock Awards During the first six months ended June 30, 2022, 120,000 restricted stock awards (“RSAs”) were issued and vested immediately on the grant date as part of transaction bonuses in recognition of efforts in connection with the Business Combination. The total compensation expense related to RSAs was $623 thousand for the three and six months ended June 30, 2022, respectively. The compensation expense was $0 for the three and six months ended June 30, 2021. The table below summarizes the total stock compensation expenses for the three and six months ended June 30, 2022 and 2021 (in thousands): 3 Months Ended 6 Months Ended June 30, June 30, 2022 2022 Research and development $ 2,209 $ 4,598 Sales and marketing expenses 256 697 General and administrative expenses 8,576 17,227 Total Stock Compensation Expenses $ 11,041 $ 22,522 3 Months Ended 6 Months Ended June 30, June 30, 2021 2021 Research and development $ 299 $ 638 Sales and marketing expenses 29 61 General and administrative expenses 193 419 Total Stock Compensation Expenses $ 521 $ 1,118 Fair Value of Common Stock and Options The fair value of each option award is estimated on the date of grant using the Black-Scholes option-pricing model that uses the assumptions noted in the table below. Expected volatility for the Company’s common stock was determined based on an average of the historical volatility of a peer group of similar public companies. The expected term of options granted was calculated using the simplified method, which represents the average of the contractual term of the option and the weighted-average vesting period of the option. The Company uses the simplified method because it does not have sufficient historical option exercise data to provide a reasonable basis upon which to estimate expected term. The assumed dividend yield is based upon the Company’s expectation of not paying dividends in the foreseeable future. The risk-free rate is based upon the U.S. Treasury yield curve in effect at the time of grant for the period equivalent to the expected life of the option. In determining the exercise prices for options granted, the Company’s board of directors has considered the fair value of the common stock as of the grant date. The fair value of the common stock has been determined by the board of directors at each award grant date based upon a variety of factors, including the results obtained from an independent third-party valuation, the Company’s financial position and historical financial performance, the status of technological developments within the Company’s products, the composition and ability of the current engineering and management team, an evaluation or benchmark of the Company’s competition, the current business climate in the marketplace, the illiquid nature of the common stock, arm’s-length The Company did not grant any stock option awards during the six months ended June 30, 2022. The range of assumptions used in the Black-Scholes option-pricing model for options issued to employees during the six months ended June 30, 2021, are as follows: June 30, 2021 Expected volatility 46.8 % Weighted-average risk-free interest rate 1.07 % Expected dividend yield 0 % Expected term (in years) 6.1 years Exercise price $ 0.21

Net Loss Per Share

Net Loss Per Share	6 Months Ended
	Jun. 30, 2022
Net Loss Per Share	13. NET LOSS PER SHARE As a result of the Business Combination (see Note 3), the Company has retroactively adjusted the weighted average shares outstanding prior to March 2, 2022 to give effect to the Exchange Ratio used to determine the number of shares of common stock into which they were converted. The following table sets forth the computation of basic and diluted net loss per share of common stock for the three and six months ended June 30, 2022, and 2021 (in thousands, except for share and per share data): Three Months Ended June 30, 2022 2021 As Restated (1) Net Loss(1) $ (12,252 ) $ (10,074 ) Basic and diluted shares Weighted-average Class A Common Stock outstanding 114,096,390 21,977,123 Loss per share for Class A Common Stock — Basic (1) $ (0.11 ) $ (0.46 ) — Diluted(1) $ (0.11 ) $ (0.46 ) Six Months Ended June 30, 2022 2021 As Restated (1) Net Loss (1) $ (29,894 ) $ (17,861 ) Basic and diluted shares Weighted-average Class A Common Stock outstanding 84,060,966 21,912,665 Loss per share for Class A Common Stock — Basic (1) $ (0.36 ) $ (0.82 ) — Diluted (1) $ (0.36 ) $ (0.82 ) (1) For discussion on the restatement adjustments, see Note 1 — Description of Business — Restatement of Condensed Consolidated Financial Statements and Immaterial Correction of Prior-Period Errors There are 3,059,273 shares of contingently issuable common stock pursuant to the earn-out The Company’s potential dilutive securities, which include stock options, restricted stock units, convertible preferred stock and warrants have been excluded from the computation of diluted net loss per share as the effect would be anti-dilutive. Therefore, the weighted average number of common shares outstanding used to calculate both basic and diluted net loss per share is the same. The Company excluded the following weighted average potential common shares from the computation of diluted net loss per share as of June 30, 2022 and June 30, 2021: June 30, 2022 2021 Convertible Series C-1 — 23,218,418 Convertible Series C Preferred Stock (1) — 54,478,261 Common Stock Warrants (1)(2) 14,176,066 1,890,514 Stock Options (1) 9,482,711 12,795,605 Restricted Stock Units (1) 11,850,526 — 35,509,303 92,382,798 (1) The number of outstanding shares as of June 30, 2021 have been retrospectively adjusted to reflect the Exchange Ratio. (2) The number of outstanding warrants as of June 30, 2022 and June 30, 2021 does not include 1,608,370 shares of Unvested Customer Warrants.

Income Taxes

Income Taxes	6 Months Ended
	Jun. 30, 2022
Income Taxes	14. INCOME TAXES The Company did not record income tax expense for the three and six months ended June 30, 2022 or the three and six months ended June 30, 2021 due to the Company’s loss position and full valuation allowance. The effective tax rate differs from the statutory rate, primarily due to the Company’s history of incurring losses, which have not been benefited, the foreign rate differential related to subsidiary earnings, and other permanent differences. Realization of deferred tax assets is dependent upon future earnings, if any, the timing and amount of which are uncertain.

Segments

Segments	6 Months Ended
	Jun. 30, 2022
Segments	15. SEGMENTS The following table presents a summary of revenue by geography for the three and six months ended June 30, 2022 and 2021 (in thousands): Three Months Ended June 30, 2022 2021 Amount % Amount % (In Thousands) (In Thousands) United States $ 1,649 77.3 % $ 593 38.5 % United Kingdom 485 22.7 % 947 61.5 % $ 2,134 100.0 % $ 1,540 100.0 % Six Months Ended June 30, 2022 2021 Amount % Amount % (In Thousands) (In Thousands) United States $ 3,550 83.8 % $ 2,783 71.4 % United Kingdom 688 16.2 % 1,117 28.6 % $ 4,238 100.0 % $ 3,900 100.0 % Revenues from external customers are attributed to individual countries based on the physical location in which the services are provided or the particular customer location with whom the Company has contracted.

Subsequent Events

Subsequent Events	6 Months Ended
	Jun. 30, 2022
Subsequent Events	16. SUBSEQUENT EVENTS The Company entered into a Common Stock Purchase Agreement with B. Riley Principal Capital II, LLC (“B. Riley”) on August 11, 2022 pursuant to which the Company may issue and sell to B. Riley the lesser of i) $ 75.0

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	6 Months Ended
	Jun. 30, 2022
Emerging Growth Company	Emerging Growth Company — The Company anticipates that it will remain an EGC under the JOBS Act until the earliest of (a) the last day of Rigetti’s first fiscal year following the fifth anniversary of the completion of SNII’s initial public offering, (b) the last date of Rigetti’s fiscal year in which Rigetti has total annual gross revenue of at least $1.07 billion, (c) the date on which Rigetti is deemed to be a “large accelerated filer” under the rules of the SEC with at least $700.0 million of outstanding securities held by non-affiliates non-convertible
Use of Estimates	Use of Estimates —
Reclassifications	Reclassifications —
Deferred Offering Costs	Deferred Offering Costs — paid-in The Company incurred $0.8 million and $0 of offering costs for both the three and six months ended June 30, 2022 and 2021, respectively, which related to filing new registration statements with the SEC after the close of the Business Combination. These costs are incremental to those disclosed in Note 3. As the shares for which the registration statements were filed were issued as of June 30, 2022, the Company recorded the costs as a reduction to additional paid-in
Deferred Financing Costs	Deferred Financing Costs —
Segments	Segments —
Foreign Currency	Foreign Currency —
Comprehensive Loss	Comprehensive Loss — non-owner
Cash and Restricted Cash	Cash and Restricted Cash — As of December 31, 2021, restricted cash consists of cash secured as collateral for letters of credit in favor of the Company’s landlord and its corporate credit card program. The following table provides a reconciliation of cash and restricted cash in the consolidated balance sheets to the total amount shown in the consolidated statements of cash flows for the six months ended June 30, 2022: (In thousands) June 30, December 31, Cash $ 184,020 $ 11,729 Restricted cash 117 317 Total cash and restricted cash $ 184,137 $ 12,046
Accounts Receivable	Accounts Receivable — write-offs,
Public and Private Warrants	Public and Private Warrants — The Private Warrants do not meet the derivative scope exception and are accounted for as derivative liabilities. Specifically, the Private Warrants contain provisions that cause the settlement amounts to be dependent upon the characteristics of the holder of the warrant which is not an input into the pricing of a fixed-for-fixed Subsequent to the separate listing and trading of the Public Warrants the fair value of the Public Warrants has been measured based on the observable listed prices for such warrants and the fair value of the Private Warrants are measured using an option pricing model. On the consummation of the Business Combination, the Company recorded a liability related to the Private Warrants of $9.6 million (as restated and discussed in Note 1), with an offsetting entry to additional paid-in Similarly, on consummation of the Business Combination, the Company recorded a liability related to the Public Warrants of $16.3 million, with an offsetting entry to additional paid-in
Derivative Warrant Liabilities	Derivative Warrant Liabilities — Other than the Public and Private Warrants noted above, the Company also has other warrants issued and outstanding which are recognized as derivative liabilities in accordance with ASC 815. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjusts the instruments to fair value at each reporting period until exercised. The fair value of the warrant liabilities issued were initially measured using the Black- Scholes model and will be subsequently remeasured at each reporting period with changes recorded as a component of other income in the Company’s consolidated statement of operations. Derivative warrant liabilities are classified as non-current
Earn-Out Liability	Earn-Out “Earn-Out These Sponsor Vesting Shares are accounted for as liability classified instruments because the Earn-Out As of June 30, 2022, the Earn-Out Significant inputs into the respective models at the March 2, 2022 (the initial recognition) and June 30, 2022 are as follows: Valuation Assumptions Initial Recognition June 30, 2022 As Restated (1) As Restated (1) Stock Price $ 9.43 $ 3.67 Simulated trading days 1,198.00 1,177.00 Volatility (annual) (1) 30.50 % 79.20 % Risk-free rate 1.74 % 2.98 % Estimated time to expiration (years) 5 4.67 (1) As restated and discussed in Note 1 — Description of Business — Restatement of Condensed Consolidated Financial Statements and Immaterial Correction of Prior-Period Errors
Revenue Recognition	Revenue Recognition — Development contracts are generally multi-year, non-recurring When the Company’s contracts with customers contain multiple performance obligations, the transaction price is allocated on a relative standalone selling price basis to each performance obligation. The Company typically determines standalone selling price based on observable selling prices of our products and services. In instances where standalone selling price is not directly observable, standalone selling price is determined using information that may include market conditions and other observable inputs. Standalone selling price is typically established as a range. In situations in which the stated contract price for a performance obligation is outside of the applicable standalone selling price range and has a different pattern of transfer to the customer than the other performance obligations in the contract, the Company will reallocate the total transaction price to each performance obligation based on the relative standalone selling price of each. The transaction price is the amount of consideration to which the Company expects to be entitled in exchange for transferring goods and services to the customer. Revenue is recorded based on the transaction price, which includes fixed consideration and estimates of variable consideration. The amount of variable consideration included in the transaction price is constrained and is included only to the extent it is probable that a significant reversal of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is subsequently resolved.
Net income (loss) per share	Net income (loss) per share — C-1 if-converted
Stock-Based Compensation	Stock-Based Compensation — 4-year change-in-control Compensation expenses are based on the grant-date fair value of the awards and recognized over the requisite service period using a straight-line method for stock options and RSUs granted under the 2022 Plan. Compensation expense for RSUs granted under the 2013 Plan are recognized using a graded vesting method. Compensation expense for RSAs are recognized fully on grant date. The Company has elected to account for forfeitures of employee stock awards as they occur.
Concentration of Credit Risk	Concentrations of Credit Risk — Significant customers that represent 10% or more of revenue are set forth in the following tables: For the Six Months Ended June 30, Customer 2022 2021 Customer A 33 % * Customer B 28 % 25 % Customer C 16 % 30 % Customer D 10 % * Customer E * 36 % For the Three Months Ended June 30, Customer 2022 2021 Customer A 32 % 30 % Customer B 22 % 64 % Customer C 19 % * Customer D 19 % * * Customer accounted for less than 10% of revenue in the respective period Significant customers that represent 10% or more of accounts receivable are set forth in the following tables: Customer June 30, December 31, 2022 2021 Customer A 25 % 35 % Customer B 24 % 34 % Customer C 16 % 29 % Customer D 16 % * Customer E 11 % * * Customer accounted for less than 10% of accounts receivable in the respective period For the three and six months ended June 30, 2022, sales to government entities comprised 67.8% and 72.0% of the Company’s total revenue, respectively. For the three and six months ended June 30, 2021, sales to government entities comprised 69.7% and 74.9% of the Company’s total revenue, respectively.
Recently Issued Accounting Pronouncements	Recently Issued Accounting Pronouncements — 2022-03, In February 2016, the FASB issued ASU 2016-02, 2016-02 2018-01, ASU2018-10, 2018-20 2019-01, 2016-02). 2016-02 right-of-use 2016-02 2016-02 2016-02, No other new accounting pronouncement recently issued or newly effective had or is expected to have a material impact on the condensed consolidated financial statements.

Description of Business (Tables

Description of Business (Tables)	6 Months Ended
	Jun. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Schedule of Restated Condensed Consolidated Balance Sheet	Restated Condensed Consolidated Balance Sheet (unaudited) As of June 30, 2022 As reported As adjusted - (a) As adjusted - (b) As adjusted - (c) As adjusted - (d) As adjusted - Total As restated Accrued expenses and other current liabilities $ 4,428 $ — $ 1,590 $ — $ — $ 1,590 $ 6,018 Total current liabilities 11,279 — 1,590 — — 1,590 12,869 Derivative warrant liabilities 8,944 — — — 3,204 3,204 12,148 Earn-out 8,925 (1,069 ) — — (1,069 ) 7,856 Total liabilities 54,765 (1,069 ) 1,590 — 3,204 3,725 58,490 Additional paid-in 401,290 6,170 — — (445 ) 5,725 407,015 Accumulated deficit (227,575 ) (5,101 ) (1,590 ) — (2,759 ) (9,450 ) (237,025 ) Total stockholders’ equity (deficit) 173,825 1,069 (1,590 ) — (3,204 ) (3,725 ) 170,100
Schedule of Restated Condensed Consolidated Statement Of Operations	Restated Condensed Consolidated Statements of Operations (unaudited) For the Three Months Ended June 30, 2022 As reported As adjusted - (a) As adjusted - (b) As adjusted - (c) As adjusted - (d) As adjusted - Total As restated Research and development $ 12,634 $ — $ 113 $ — $ — $ 113 $ 12,747 Total operating expenses 26,906 — 113 — — 113 27,019 Loss from operations (25,645 ) — (113 ) — — (113 ) (25,758 ) Change in fair value of derivate warrant liabilities 8,687 — — (1,331 ) 624 (707 ) 7,980 Change in fair value of earn-out 8,024 (1,458 ) — — — (1,458 ) 6,566 Total other income (expense), net 15,671 (1,458 ) — (1,331 ) 624 (2,165 ) 13,506 Net loss $ (9,974 ) $ (1,458 ) $ (113 ) $ (1,331 ) $ 624 $ (2,278 ) $ (12,252 ) Net loss per share attributed to common stockholders - basic and diluted $ (0.09 ) $ (0.02 ) $ (0.11 ) For the Six Months Ended June 30, 2022 As reported As adjusted - (a) As adjusted - (b) As adjusted - (c) As adjusted - (d) As adjusted - Total As restated Research and development $ 25,083 $ — $ 1,590 $ — $ — $ 1,590 $ 26,673 Total operating expenses 52,391 — 1,590 — — 1,590 53,981 Loss from operations (49,440 ) — (1,590 ) — — (1,590 ) (51,030 ) Change in fair value of derivate warrant liabilities 14,509 — — — (2,759 ) (2,759 ) 11,750 Change in fair value of earn-out 17,658 (5,101 ) — — (5,101 ) 12,557 Total other income (expense), net 28,996 (5,101 ) — — (2,759 ) (7,860 ) 21,136 Net loss $ (20,444 ) $ (5,101 ) $ (1,590 ) $ — $ (2,759 ) $ (9,450 ) $ (29,894 ) Net loss per share attributed to common stockholders - basic and diluted $ (0.24 ) $ (0.12 ) $ (0.36 )
Schedule of Restated Condensed Consolidated Statement of Redeemable Convertible Preferred Stock and Stockholder's (Deficit) Equity	Restated Condensed Consolidated Statement of Redeemable Convertible Preferred Stock and Stockholder’s (Deficit) Equity (unaudited) as of June 30, 2022 For the Six Months Ended As reported As adjusted - (a) As adjusted - (b) As adjusted - (c) As adjusted - (d) As adjusted - Total As Restated Additional Paid-In $ 401,290 $ 6,170 $ — $ — $ (445 ) $ 5,725 $ 407,015 Accumulated deficit (227,575 ) (5,101 ) (1,590 ) — (2,759 ) (9,450 ) (237,025 ) Total Stockholders’ (Deficit) Equity 173,825 1,069 (1,590 ) — (3,204 ) (3,725 ) 170,100
Schedule of Restated Condensed Consolidated Statement of Cash Flows	Restated Condensed Consolidated Statement of Cash Flows (unaudited) For the Six Months Ended As reported As adjusted - (a) As adjusted - (b) As adjusted - (c) As adjusted - (d) As adjusted - Total As restated Net loss $ (20,444 ) $ (5,101 ) $ (1,590 ) $ — $ (2,759 ) $ (9,450 ) $ (29,894 ) Accrued expenses and other current liabilities 967 — 1,590 — — 1,590 2,557 Change in fair value of derivative warrant liabilities (14,509 ) — — — 2,759 2,759 (11,750 ) Change in fair value of earnout liability (17,658 ) 5,101 — — — 5,101 (12,557 ) Net cash used in operating activities (35,085 ) — — — — — (35,085 )

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	6 Months Ended
	Jun. 30, 2022
Cash, Cash Equivalents and Investments	The following table provides a reconciliation of cash and restricted cash in the consolidated balance sheets to the total amount shown in the consolidated statements of cash flows for the six months ended June 30, 2022: (In thousands) June 30, December 31, Cash $ 184,020 $ 11,729 Restricted cash 117 317 Total cash and restricted cash $ 184,137 $ 12,046
Schedule of Inputs Into the Respective Models	Significant inputs into the respective models at the March 2, 2022 (the initial recognition) and June 30, 2022 are as follows: Valuation Assumptions Initial Recognition June 30, 2022 As Restated (1) As Restated (1) Stock Price $ 9.43 $ 3.67 Simulated trading days 1,198.00 1,177.00 Volatility (annual) (1) 30.50 % 79.20 % Risk-free rate 1.74 % 2.98 % Estimated time to expiration (years) 5 4.67 (1) As restated and discussed in Note 1 — Description of Business — Restatement of Condensed Consolidated Financial Statements and Immaterial Correction of Prior-Period Errors
Schedule of Calculation of Basic and Diluted Net Income (Loss) Per Ordinary Shares	Significant customers that represent 10% or more of revenue are set forth in the following tables: For the Six Months Ended June 30, Customer 2022 2021 Customer A 33 % * Customer B 28 % 25 % Customer C 16 % 30 % Customer D 10 % * Customer E * 36 % For the Three Months Ended June 30, Customer 2022 2021 Customer A 32 % 30 % Customer B 22 % 64 % Customer C 19 % * Customer D 19 % * * Customer accounted for less than 10% of revenue in the respective period
Schedule of Customers Accounts Receivable	Significant customers that represent 10% or more of accounts receivable are set forth in the following tables: Customer June 30, December 31, 2022 2021 Customer A 25 % 35 % Customer B 24 % 34 % Customer C 16 % 29 % Customer D 16 % * Customer E 11 % * * Customer accounted for less than 10% of accounts receivable in the respective period

Business Combination (Tables)

Business Combination (Tables)	6 Months Ended
	Jun. 30, 2022
Business Combinations [Abstract]
Summary of net proceeds from business combination and PIPE financing	In accounting for the Business Combination and after redemptions, net proceeds received by the Company totaled $225.6 million. The table below shows the net proceeds from business combination and PIPE financing (in thousands): Amount (in thousands) Cash - SNII trust and cash (net of redemption) $ 77,769 Cash - PIPE 147,510 Cash - SNII operating account 325 Net Proceeds from Business Combination and PIPE $ 225,604
Summary of consummation of the business combination	The number of shares of common stock issued immediately following the consummation of the Business Combination was as follows: Common Stock—SNII Class A, outstanding prior to Business Combination 34,500,000 Less: redemption of SNII Class A ordinary shares (22,915,538 ) Common Stock—SNII Class A ordinary shares 11,584,462 Common Stock—SNII Class B ordinary shares* 8,625,000 Shares issued in PIPE 14,641,244 Business Combination and PIPE shares 34,850,706 Common stock—Legacy Rigetti** 18,221,069 Common stock—exercise of Legacy Rigetti stock options immediately prior to the closing** 1,123,539 Common stock—exercise of Legacy Rigetti warrants immediately prior to the closing** 2,234,408 Common stock—upon conversion of Legacy Rigetti Series C preferred stock** 54,478,261 Common stock—upon conversion of Legacy Rigetti Series C-1 2,902,302 Total shares of common stock immediately after Business Combination 113,810,285 * Includes (i) 2,479,000 shares of Common Stock held by the Sponsor (the “Promote Sponsor Vesting Shares”) and (ii) 580,273 shares of Common Stock held by the Sponsor (“Sponsor Redemption-Based Vesting Shares”). ** (i) all outstanding shares of Legacy Rigetti Common Stock as of immediately prior to the Closing (including Legacy Rigetti Common Stock resulting from the Legacy Rigetti Preferred Stock Conversion), were exchanged at an exchange ratio of 0.7870 (the “Exchange Ratio”). (ii) the conversion ratio to Legacy Rigetti Common Stock for the Legacy Series C Preferred Stock was one-for-one eight-for-one.

Revenue Recognition (Tables)

Revenue Recognition (Tables)	6 Months Ended
	Jun. 30, 2022
Disaggregation of Revenue [Line Items]
Summary of Disaggregation of Revenue	The following tables depict the disaggregation of revenue according to the type of good or service and timing of transfer of goods or services for the three and six months ended June 30, 2022 and June 30, 2021: Three Months Ended Three Months Ended Six Months Ended Six Months Ended June 30, June 30, June 30, June 30, 2022 2021 2022 2021 (In thousands) (In thousands) Type of Goods or Service Collaborative research and other professional services $ 1,477 $ 944 $ 2,992 $ 2,547 Access to quantum computing systems 657 596 1,246 1,353 $ 2,134 $ 1,540 $ 4,238 $ 3,900 Timing of Revenue Recognition Revenue recognized at a point in time $ — $ — $ — $ — Revenue recognized over time 2,134 1,540 4,238 3,900 $ 2,134 $ 1,540 $ 4,238 $ 3,900
Summary of Contract with Customer, Contract Asset, Contract Liability, and Receivable	Selected condensed consolidated balance sheet line items that reflect accounts receivable, contract assets and liabilities as of June 30, 2022 and December 31, 2021 were as follows: June 30, December 31, 2022 2021 (In thousands) Trade receivables $ 2,350 $ 961 Unbilled receivables $ 222 $ 582 Deferred revenue $ (1,108 ) $ (985 )
Summary of Change in Contract with Customer, Asset and Liability	Changes in deferred revenue from contracts with customers were as follows: Six Months Ended 2022 (In thousands) Balance at beginning of period $ (985 ) Deferral of revenue (673 ) Recognition of deferred revenue 550 Balance at end of period $ (1,108 )

Commitments and Contingencies (

Commitments and Contingencies (Tables)	6 Months Ended
	Jun. 30, 2022
Lessee, Operating Lease, Liability, Payment, Due [Abstract]
Summary of Future Minimum Lease Payments Under Non-Cancelable Operating Leases	Future minimum lease payments under non-cancelable As of June 30, 2022 (in thousands) Remainder of 2022 $ 879 2023 1,262 2024 1,299 2025 1,338 2026 1,379 Thereafter 4,006 Total minimum future lease payments $ 10,163

Financing Arrangements (Tables)

Financing Arrangements (Tables)	6 Months Ended
	Jun. 30, 2022
Debt Disclosure [Abstract]
Long term debt and the unamortized discount	The book value of debt approximates its fair value given its maturity and variable interest rate. Long term debt and the unamortized discount balances are as follows (in thousands): June 30, December 31, 2022 2021 (in thousands) Outstanding principal amount $ 32,000 $ 27,000 Add: accreted liability of final payment fee 256 125 Less: unamortized debt discount, long term (2,117 ) (1,618 ) Less: current portion of long term debt-principal (4,938 ) (1,291 ) Debt-net of current portion $ 25,201 $ 24,216 Current portion of long term debt - principal $ 4,938 $ 1,291 Less: current portion of unamortized debt discount (712 ) (716 ) Debt-current portion $ 4,226 $ 575
Scheduled principal payments on total outstanding debt	Scheduled principal payments on total outstanding debt, as of June 30, 2022, are as follows (in thousands): June 30, December 31, 2022 2021 (in thousnds) 2022 $ 702 $ 702 2023 9,273 8,682 2024 12,914 11,008 2025 8,734 6,608 2026 377 — $ 32,000 $ 27,000

Common Stock (Tables)

Common Stock (Tables)	6 Months Ended
	Jun. 30, 2022
Class of Stock [Line Items]
Summary of Conversions of Stock	As of June 30, 2022, the Company has reserved the following shares of common stock for issuance upon the conversion, exercise or vesting of the underlying instruments: Common Stock Common Stock Warrants 18,126,014 Stock-Based Awards - RSUs Outstanding 11,850,526 Stock-Based Awards - Options Outstanding 9,482,711 Total 39,459,251

Warrants (Tables)

Warrants (Tables)	6 Months Ended
	Jun. 30, 2022
Class of Warrant or Right [Line Items]
Schedule Of Fair Value Of The Common Stock Warrant Liabilities Measured Using Black Scholes Approach	The fair value of the Trinity Warrant liabilities presented above were measured using the Black Scholes model approach. Significant inputs into the respective models at June 2, 2022, the exercise date of the Trinity Warrants, are as follows: Valuation Assumption - June 2 2022 Stock price $ 8.23 Strike price $ 0.27 Volatility (annual) 105.10 % Risk-free rate 2.94 % Estimated time to expiration (years) 9 Dividend yield — %
Summary of vesting status of the Customer Warrant	The vesting status of the Customer Warrant is as follows at June 30, 2022 and December 31, 2021: June 30, December 31, Vested Customer warrants 1,072,237 1,072,237 Unvested Customer warrants 1,608,370 1,608,359 2,680,607 2,680,596
Warrants To Purchase Class A Common Stock [Member]
Class of Warrant or Right [Line Items]
Schedule Of Fair Value Of The Common Stock Warrant Liabilities Measured Using Black Scholes Approach	The fair value of the Private Warrant was measured using the Black Scholes model approach. Significant inputs into the respective models at March 2, 2022 (the initial recognition) and June 30, 2022 are as follows: Valuation Assumptions Initial Recognition on March 2, June 30, 2022 As Restated (1) As Restated (1) Stock Price $ 9.43 $ 3.67 Strike Price $ 11.50 $ 11.50 Volatility (annual) (1) 30.66 % 79.03 % Risk-free rate 1.74 % 3.01 % Estimated time to expiration (years) 5 4.672 Dividend yield — % — % (1) As restated and discussed in Note 1 — Description of Business — Restatement of Condensed Consolidated Financial Statements and Immaterial Correction of Prior-Period Errors

Forward Warrant Agreement (Tabl

Forward Warrant Agreement (Tables)	6 Months Ended
	Jun. 30, 2022
Temporary Equity [Line Items]
Summary of Fair Value Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques	The following table represents key valuation assumptions as of the quarter ended June 30, 2022. Key Valuation Assumptions Holding period (in years) 0.000 - 0.628 Risk free rate 0.00% - 2.57% Probability of contingency occurrence 50% - 100% Underlying value per share $3.39 - $3.67

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	6 Months Ended
	Jun. 30, 2022
Summary of Information About Assets and Liabilities Measured at Fair Value on Recurring Basis	The fair value measurements of financial assets and liabilities that are measured at fair value at June 30, 2022 and December 31, 2021 are as follows: June 30, 2022 Level 1 Level 2 Level 3 As Restated (1) (in thousands) Assets: Forward Warrant Agreement $ — $ — $ 1,543 Total Assets $ — $ — $ 1,543 Liabilities: Derivative warrant liability-Private Warrants, as restated (1) — — 6,542 Derivative warrant liability-Public Warrants 5,606 — — Earn-out — 7,856 Total liabilities, as restated (1) $ 5,606 $ — $ 14,398 December 31, 2021 Level 1 Level 2 Level 3 (in thousands) Liabilities: Derivative warrant liability - Trinity Warrants — 4,355 Forward warrant agreement — — 230 Total liabilities $ — $ — $ 4,585 (1) For discussion on the restatement adjustments, see Note 1 — Description of Business — Restatement of Condensed Consolidated Financial Statements and Immaterial Correction of Prior-Period Errors
Change in Fair Value of Derivative Liabilities	A summary of the changes in the fair value of the Company’s Level 3 financial instruments as of June 30, 2022 and December 31, 2021 are as follows: Derivative warrant Derivative warrant Forward Earn-out Liability, (in thousands) Balance - December 31, 2021 $ 4,355 $ — $ 230 $ — Initial measurement on March 2, 2022 upon Business Combination, as restated (Note 3) (1) 9,612 20,413 Change in fair values, as restated (1) 2,015 (3,070 ) (5,078 ) (12,557 ) Extinguishment due to exercise of the warrants (6,370 ) — 3,305 — Balance - June 30, 2022, as restated (1) $ — $ 6,542 $ (1,543 ) $ 7,856 (1) For discussion on the restatement adjustments, see Note 1 — Description of Business — Restatement of Condensed Consolidated Financial Statements and Immaterial Correction of Prior-Period Errors

Equity Plans - (Tables)

Equity Plans - (Tables)	6 Months Ended
	Jun. 30, 2022
Schedule Of Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Grant Date Intrinsic Value [Table Text Block]	A summary of activity related to stock option is summarized as below (in thousands, except for share and per share data): Number of Options Weighted-Average Exercise Price Weighted-average Aggregate Outstanding – December 31, 2021 11,468,275 $ 0.36 8.1 $ 46,839 Granted — Exercised (1,353,145 ) $ 0.27 7,104 Forfeited and expired (632,419 ) $ 0.27 Outstanding - June 30, 2022 9,482,711 $ 0.35 7.7 $ 31,454 Exercisable - June 30, 2022 5,874,426 $ 0.39 7.7 $ 19,258
Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs	The table below summarizes the total stock compensation expenses for the three and six months ended June 30, 2022 and 2021 (in thousands): 3 Months Ended 6 Months Ended June 30, June 30, 2022 2022 Research and development $ 2,209 $ 4,598 Sales and marketing expenses 256 697 General and administrative expenses 8,576 17,227 Total Stock Compensation Expenses $ 11,041 $ 22,522 3 Months Ended 6 Months Ended June 30, June 30, 2021 2021 Research and development $ 299 $ 638 Sales and marketing expenses 29 61 General and administrative expenses 193 419 Total Stock Compensation Expenses $ 521 $ 1,118
Schedule Of Share Based Payment Award Stock Options Valuation Assumptions	The Company did not grant any stock option awards during the six months ended June 30, 2022. The range of assumptions used in the Black-Scholes option-pricing model for options issued to employees during the six months ended June 30, 2021, are as follows: June 30, 2021 Expected volatility 46.8 % Weighted-average risk-free interest rate 1.07 % Expected dividend yield 0 % Expected term (in years) 6.1 years Exercise price $ 0.21
Schedule of Activity Related to Restricted Stock Units	A summary of activity related to RSUs is summarized as below: RSUs Weighted Average Balance at December 31, 2021 5,388,455 Granted 9,885,413 $ 4.89 Vested (2,630,699 ) Forfeited (792,643 ) Balance at June 30, 2022 11,850,526

Net Loss Per Share (Tables)

Net Loss Per Share (Tables)	6 Months Ended
	Jun. 30, 2022
Schedule of Earnings Per Share Basic Aand Diluted	The following table sets forth the computation of basic and diluted net loss per share of common stock for the three and six months ended June 30, 2022, and 2021 (in thousands, except for share and per share data): Three Months Ended June 30, 2022 2021 As Restated (1) Net Loss(1) $ (12,252 ) $ (10,074 ) Basic and diluted shares Weighted-average Class A Common Stock outstanding 114,096,390 21,977,123 Loss per share for Class A Common Stock — Basic (1) $ (0.11 ) $ (0.46 ) — Diluted(1) $ (0.11 ) $ (0.46 ) Six Months Ended June 30, 2022 2021 As Restated (1) Net Loss (1) $ (29,894 ) $ (17,861 ) Basic and diluted shares Weighted-average Class A Common Stock outstanding 84,060,966 21,912,665 Loss per share for Class A Common Stock — Basic (1) $ (0.36 ) $ (0.82 ) — Diluted (1) $ (0.36 ) $ (0.82 ) (1) For discussion on the restatement adjustments, see Note 1 — Description of Business — Restatement of Condensed Consolidated Financial Statements and Immaterial Correction of Prior-Period Errors
Schedule of Antidilutive Securities Excluded From Computation of Earnings	The Company excluded the following weighted average potential common shares from the computation of diluted net loss per share as of June 30, 2022 and June 30, 2021: June 30, 2022 2021 Convertible Series C-1 — 23,218,418 Convertible Series C Preferred Stock (1) — 54,478,261 Common Stock Warrants (1)(2) 14,176,066 1,890,514 Stock Options (1) 9,482,711 12,795,605 Restricted Stock Units (1) 11,850,526 — 35,509,303 92,382,798 (1) The number of outstanding shares as of June 30, 2021 have been retrospectively adjusted to reflect the Exchange Ratio. (2) The number of outstanding warrants as of June 30, 2022 and June 30, 2021 does not include 1,608,370 shares of Unvested Customer Warrants.

Segments (Tables)

Segments (Tables)	6 Months Ended
	Jun. 30, 2022
Summary of Revenue by Geography	The following table presents a summary of revenue by geography for the three and six months ended June 30, 2022 and 2021 (in thousands): Three Months Ended June 30, 2022 2021 Amount % Amount % (In Thousands) (In Thousands) United States $ 1,649 77.3 % $ 593 38.5 % United Kingdom 485 22.7 % 947 61.5 % $ 2,134 100.0 % $ 1,540 100.0 % Six Months Ended June 30, 2022 2021 Amount % Amount % (In Thousands) (In Thousands) United States $ 3,550 83.8 % $ 2,783 71.4 % United Kingdom 688 16.2 % 1,117 28.6 % $ 4,238 100.0 % $ 3,900 100.0 %

Description of Business - Addit

Description of Business - Additional Information (Details) - USD ($)				3 Months Ended						6 Months Ended
	Jun. 30, 2022		Mar. 02, 2022	Jun. 30, 2022		Mar. 31, 2022		Jun. 30, 2021	Mar. 31, 2021	Jun. 30, 2022		Jun. 30, 2021	Dec. 31, 2021		Dec. 31, 2020
Description Of Organization Business Operations And Basis Of Presentation [Line Items]
Common Stock, Par or Stated Value Per Share	$ 0.0001			$ 0.0001						$ 0.0001			$ 0.0001
Accumulated deficit	$ 237,025,000			$ 237,025,000						$ 237,025,000			$ 207,131,000
Number of trading days for determining the share price	20 days		20 days
Stockholders'(Deficit) Equity	$ (170,100,000)	[1]		(170,100,000)	[1]	$ (163,983,000)	[1]	$ 48,832,000	$ 39,368,000	(170,100,000)	[1]	$ 48,832,000	$ 71,528,000	[1]	$ 32,256,000
Net loss				$ (12,252,000)	[1]	(17,642,000)	[1]	(10,074,000)	$ (7,787,000)	(29,894,000)	[1]	(17,861,000)
Net cash in operating activities										$ (35,085,000)	[1]	(14,098,000)
Class of warrants or rights outstanding	2,680,607			2,680,607						2,680,607			2,680,596
Accrual operating expenses				$ 27,019,000				10,851,000		$ 53,981,000		20,620,000
Out-of-period adjustment				(25,758,000)				$ (9,676,000)		(51,030,000)		$ (17,357,000)
Restatement Adjustment [Member]
Description Of Organization Business Operations And Basis Of Presentation [Line Items]
Accumulated deficit	$ 9,450,000			9,450,000						9,450,000
Stockholders'(Deficit) Equity	$ 3,725,000			3,725,000						3,725,000
Net loss				(2,278,000)						(9,450,000)
Net cash in operating activities										0
Derivative liabilities						1,300,000
Change in fair value of derivative warrant liabilities						1,300,000
Accrual operating expenses				113,000		1,500,000				1,590,000
Out-of-period adjustment				$ 113,000		$ 1,300,000				$ 1,590,000
Supernova Acquistion [Member] | Sponsor Agreement [Member] | Tranche One [Member]
Description Of Organization Business Operations And Basis Of Presentation [Line Items]
Shares subject to vesting	2,479,000			2,479,000						2,479,000
Shares subject to vesting maximum period	5 years
Volume weighted average price per share	$ 12.5
Number Of Consecutive Trading Days For Determining The Share Price	30 days
Supernova Acquistion [Member] | Sponsor Agreement [Member] | Tranche Two [Member]
Description Of Organization Business Operations And Basis Of Presentation [Line Items]
Shares subject to vesting	580,273			580,273						580,273
Shares subject to vesting maximum period	5 years
Volume weighted average price per share	$ 15
Number Of Consecutive Trading Days For Determining The Share Price	30 days
Supernova Acquistion [Member] | Restatement Adjustment [Member] | Sponsor Agreement [Member] | Tranche One [Member]
Description Of Organization Business Operations And Basis Of Presentation [Line Items]
Shares subject to vesting			2,479,000
Shares subject to vesting maximum period			5 years
Volume weighted average price per share			$ 12.5
Number Of Consecutive Trading Days For Determining The Share Price			30 days
Supernova Acquistion [Member] | Restatement Adjustment [Member] | Sponsor Agreement [Member] | Tranche Two [Member]
Description Of Organization Business Operations And Basis Of Presentation [Line Items]
Shares subject to vesting			580,273
Shares subject to vesting maximum period			5 years
Volume weighted average price per share			$ 15
Number Of Consecutive Trading Days For Determining The Share Price			30 days
Private Placement Warrants
Description Of Organization Business Operations And Basis Of Presentation [Line Items]
Exercise price of warrants	$ 11.5			$ 11.5						$ 11.5
Derivative liabilities	$ 9,600,000			$ 9,600,000						$ 9,600,000
Class of warrants or rights outstanding	4,450,000			4,450,000						4,450,000
Warrants and rights outstanding, term	5 years			5 years						5 years
Private Placement Warrants | Restatement Adjustment [Member]
Description Of Organization Business Operations And Basis Of Presentation [Line Items]
Exercise price of warrants	$ 11.5			$ 11.5						$ 11.5
Temporary equity, shares subject to possible redemption price per share	$ 18			$ 18						$ 18
Class of warrants or rights outstanding	4,450,000			4,450,000						4,450,000
Warrants and rights outstanding, term	5 years			5 years						5 years
Temporary equity not subject to redemption price per share	$ 10			$ 10						$ 10
Class A Ordinary Shares | Conversion Of Common Stock Shares From The Previous Company To The Current Company [Member]
Description Of Organization Business Operations And Basis Of Presentation [Line Items]
Common Stock, Par or Stated Value Per Share			$ 0.0001
Class B Ordinary Shares | Conversion Of Common Stock Shares From The Previous Company To The Current Company [Member]
Description Of Organization Business Operations And Basis Of Presentation [Line Items]
Common Stock, Par or Stated Value Per Share			$ 0.0001
[1]For discussion on the restatement adjustments, see Note 1 — Description of Business — Restatement of Condensed Consolidated Financial Statements and Immaterial Correction of Prior-Period Errors

Description of Business - Sched

Description of Business - Schedule of Restated Condensed Consolidated Balance Sheet (Details) - USD ($) $ in Thousands	Jun. 30, 2022		Mar. 31, 2022	[1]	Dec. 31, 2021		Jun. 30, 2021	Mar. 31, 2021	Dec. 31, 2020
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Accrued expenses and other current liabilities	$ 6,018				$ 3,806
Total current liabilities	12,869				7,567
Derivative warrant liabilities	12,148				4,355
Earn-out liabilities	7,856				0
Total liabilities	58,490				36,433
Additional paid-in capital	407,015				135,549
Accumulated deficit	(237,025)				(207,131)
Total stockholders' equity (deficit)	170,100	[1]	$ 163,983		$ (71,528)	[1]	$ (48,832)	$ (39,368)	$ (32,256)
As Reported
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Accrued expenses and other current liabilities	4,428
Total current liabilities	11,279
Derivative warrant liabilities	8,944
Earn-out liabilities	8,925
Total liabilities	54,765
Additional paid-in capital	401,290
Accumulated deficit	(227,575)
Total stockholders' equity (deficit)	173,825
To Be Adjusted (a)
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Accrued expenses and other current liabilities	0
Total current liabilities	0
Derivative warrant liabilities	0
Earn-out liabilities	(1,069)
Total liabilities	(1,069)
Additional paid-in capital	6,170
Accumulated deficit	(5,101)
Total stockholders' equity (deficit)	1,069
To Be Adjusted (b)
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Accrued expenses and other current liabilities	1,590
Total current liabilities	1,590
Derivative warrant liabilities	0
Earn-out liabilities	0
Total liabilities	1,590
Additional paid-in capital	0
Accumulated deficit	(1,590)
Total stockholders' equity (deficit)	(1,590)
To Be Adjusted (c)
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Accrued expenses and other current liabilities	0
Total current liabilities	0
Derivative warrant liabilities	0
Earn-out liabilities	0
Total liabilities	0
Additional paid-in capital	0
Accumulated deficit	0
Total stockholders' equity (deficit)	0
To Be Adjusted (d)
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Accrued expenses and other current liabilities	0
Total current liabilities	0
Derivative warrant liabilities	3,204
Total liabilities	3,204
Additional paid-in capital	(445)
Accumulated deficit	(2,759)
Total stockholders' equity (deficit)	(3,204)
To Be Adjusted
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Accrued expenses and other current liabilities	1,590
Total current liabilities	1,590
Derivative warrant liabilities	3,204
Earn-out liabilities	(1,069)
Total liabilities	3,725
Additional paid-in capital	5,725
Accumulated deficit	(9,450)
Total stockholders' equity (deficit)	(3,725)
As Restated
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Accrued expenses and other current liabilities	6,018
Total current liabilities	12,869
Derivative warrant liabilities	12,148
Earn-out liabilities	7,856
Total liabilities	58,490
Additional paid-in capital	407,015
Accumulated deficit	(237,025)
Total stockholders' equity (deficit)	$ 170,100
[1]For discussion on the restatement adjustments, see Note 1 — Description of Business — Restatement of Condensed Consolidated Financial Statements and Immaterial Correction of Prior-Period Errors

Description of Business - Sch_2

Description of Business - Schedule Of Restated Condensed Consolidated Statement of Operations (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended						6 Months Ended
	Jun. 30, 2022		Mar. 31, 2022		Jun. 30, 2021	Mar. 31, 2021	Jun. 30, 2022		Jun. 30, 2021
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Research and development	$ 12,747				$ 7,496		$ 26,673		$ 14,431
Total operating expenses	27,019				10,851		53,981		20,620
Loss from operations	25,758				9,676		51,030		17,357
Change in fair value of derivative warrant liabilities	(7,980)				0		(11,750)	[1]	0
Change in fair value of earn-out liability	(6,566)				0		(12,557)	[1]	0
Total other (expense) income, net	13,506				(398)		21,136		(504)
Net loss	$ (12,252)	[1]	$ (17,642)	[1]	$ (10,074)	$ (7,787)	$ (29,894)	[1]	$ (17,861)
Net loss per share attributed to common stockholders—basic	$ (0.11)				$ (0.46)		$ (0.36)		$ (0.82)
Net loss per share attributed to common stockholders—diluted	$ (0.11)				$ (0.46)		$ (0.36)		$ (0.82)
As Reported
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Research and development	$ 12,634						$ 25,083
Total operating expenses	26,906						52,391
Loss from operations	(25,645)						(49,440)
Change in fair value of derivative warrant liabilities	8,687						14,509
Change in fair value of earn-out liability	8,024						17,658
Total other (expense) income, net	15,671						28,996
Net loss	$ (9,974)						$ (20,444)
Net loss per share attributed to common stockholders—basic	$ (0.09)						$ (0.24)
Net loss per share attributed to common stockholders—diluted	$ (0.09)						$ (0.24)
To Be Adjusted (a)
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Research and development	$ 0						$ 0
Total operating expenses	0						0
Loss from operations	0						0
Change in fair value of derivative warrant liabilities	0						0
Change in fair value of earn-out liability	(1,458)						(5,101)
Total other (expense) income, net	(1,458)						(5,101)
Net loss	(1,458)						(5,101)
To Be Adjusted (b)
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Research and development	113						1,590
Total operating expenses	113						1,590
Loss from operations	(113)						(1,590)
Change in fair value of derivative warrant liabilities	0						0
Change in fair value of earn-out liability	0						0
Total other (expense) income, net	0						0
Net loss	(113)						(1,590)
To Be Adjusted (c)
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Research and development	0						0
Total operating expenses	0						0
Loss from operations	0						0
Change in fair value of derivative warrant liabilities	(1,331)						0
Change in fair value of earn-out liability	0						0
Total other (expense) income, net	(1,331)						0
Net loss	(1,331)						0
To Be Adjusted (d)
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Research and development	0						0
Total operating expenses	0						0
Loss from operations	0						0
Change in fair value of derivative warrant liabilities	624						(2,759)
Change in fair value of earn-out liability	0						0
Total other (expense) income, net	624						(2,759)
Net loss	624						(2,759)
To Be Adjusted
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Research and development	113						1,590
Total operating expenses	113		1,500				1,590
Loss from operations	(113)		$ (1,300)				(1,590)
Change in fair value of derivative warrant liabilities	(707)						(2,759)
Change in fair value of earn-out liability	(1,458)						(5,101)
Total other (expense) income, net	(2,165)						(7,860)
Net loss	$ (2,278)						$ (9,450)
Net loss per share attributed to common stockholders—basic	$ (0.02)						$ (0.12)
Net loss per share attributed to common stockholders—diluted	$ (0.02)						$ (0.12)
As Restated
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Research and development	$ 12,747						$ 26,673
Total operating expenses	27,019						53,981
Loss from operations	(25,758)						(51,030)
Change in fair value of derivative warrant liabilities	7,980						11,750
Change in fair value of earn-out liability	6,566						12,557
Total other (expense) income, net	13,506						21,136
Net loss	$ (12,252)						$ (29,894)
Net loss per share attributed to common stockholders—basic	$ (0.11)						$ (0.36)
Net loss per share attributed to common stockholders—diluted	$ (0.11)						$ (0.36)
[1]For discussion on the restatement adjustments, see Note 1 — Description of Business — Restatement of Condensed Consolidated Financial Statements and Immaterial Correction of Prior-Period Errors

Description of Business - Sch_3

Description of Business - Schedule of Restated Condensed Consolidated Statement of Redeemable Convertible Preferred Stock and Stockholder's (Deficit) Equity (Details) - USD ($) $ in Thousands	Jun. 30, 2022		Mar. 31, 2022	[1]	Dec. 31, 2021		Jun. 30, 2021	Mar. 31, 2021	Dec. 31, 2020
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Additional Paid-In Capital	$ 407,015				$ 135,549
Accumulated deficit	(237,025)				(207,131)
Total Stockholders'(Deficit) Equity	170,100	[1]	$ 163,983		$ (71,528)	[1]	$ (48,832)	$ (39,368)	$ (32,256)
As Reported
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Additional Paid-In Capital	401,290
Accumulated deficit	(227,575)
Total Stockholders'(Deficit) Equity	173,825
To Be Adjusted (a)
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Additional Paid-In Capital	6,170
Accumulated deficit	(5,101)
Total Stockholders'(Deficit) Equity	1,069
To Be Adjusted (b)
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Additional Paid-In Capital	0
Accumulated deficit	(1,590)
Total Stockholders'(Deficit) Equity	(1,590)
To Be Adjusted (c)
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Additional Paid-In Capital	0
Accumulated deficit	0
Total Stockholders'(Deficit) Equity	0
To Be Adjusted (d)
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Additional Paid-In Capital	(445)
Accumulated deficit	(2,759)
Total Stockholders'(Deficit) Equity	(3,204)
To Be Adjusted
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Additional Paid-In Capital	5,725
Accumulated deficit	(9,450)
Total Stockholders'(Deficit) Equity	(3,725)
As Restated
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Additional Paid-In Capital	407,015
Accumulated deficit	(237,025)
Total Stockholders'(Deficit) Equity	$ 170,100
[1]For discussion on the restatement adjustments, see Note 1 — Description of Business — Restatement of Condensed Consolidated Financial Statements and Immaterial Correction of Prior-Period Errors

Description of Business - Sch_4

Description of Business - Schedule of Restated Condensed Consolidated Statement of Cash Flows (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022		Jun. 30, 2021
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net loss			$ (29,894,000)	[1]	$ (17,861,000)
Accrued expenses and other current liabilities			2,557,000	[1]	692,000
Change in fair value of derivative warrant liabilities	$ 7,980,000	$ 0	11,750,000	[1]	0
Change in fair value of earn-out liability	6,566,000	$ 0	12,557,000	[1]	0
Net cash in operating activities			(35,085,000)	[1]	$ (14,098,000)
As Reported
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net loss			(20,444,000)
Accrued expenses and other current liabilities			967,000
Change in fair value of derivative warrant liabilities	(8,687,000)		(14,509,000)
Change in fair value of earn-out liability	(8,024,000)		(17,658,000)
Net cash in operating activities			(35,085,000)
To Be Adjusted (a)
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net loss			(5,101,000)
Accrued expenses and other current liabilities			0
Change in fair value of derivative warrant liabilities	0		0
Change in fair value of earn-out liability	1,458,000		5,101,000
Net cash in operating activities			0
To Be Adjusted (b)
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net loss			(1,590,000)
Accrued expenses and other current liabilities			1,590,000
Change in fair value of derivative warrant liabilities	0		0
Change in fair value of earn-out liability	0		0
Net cash in operating activities			0
To Be Adjusted (c)
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net loss			0
Accrued expenses and other current liabilities			0
Change in fair value of derivative warrant liabilities	1,331,000		0
Change in fair value of earn-out liability	0		0
Net cash in operating activities			0
To Be Adjusted (d)
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net loss			(2,759,000)
Accrued expenses and other current liabilities			0
Change in fair value of derivative warrant liabilities	(624,000)		2,759,000
Change in fair value of earn-out liability	0		0
Net cash in operating activities			0
To Be Adjusted
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net loss			(9,450,000)
Accrued expenses and other current liabilities			1,590,000
Change in fair value of derivative warrant liabilities	707,000		2,759,000
Change in fair value of earn-out liability	1,458,000		5,101,000
Net cash in operating activities			0
As Restated
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net loss			(29,894,000)
Accrued expenses and other current liabilities			2,557,000
Change in fair value of derivative warrant liabilities	(7,980,000)		(11,750,000)
Change in fair value of earn-out liability	$ (6,566,000)		(12,557,000)
Net cash in operating activities			$ (35,085,000)
[1]For discussion on the restatement adjustments, see Note 1 — Description of Business — Restatement of Condensed Consolidated Financial Statements and Immaterial Correction of Prior-Period Errors

Summary of Significant Accoun_4

Summary of Significant Accounting Policies - Additional Information (Details) $ / shares in Units, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2022 USD ($) $ / shares shares	Jun. 30, 2021 USD ($)	Jun. 30, 2022 USD ($) OperatingSegment ReportingSegment $ / shares shares		Jun. 30, 2021 USD ($)	Mar. 02, 2022 USD ($)	Dec. 31, 2021 shares
Summary Of Significant Accounting Policies [Line Items]
Number of operating segments | OperatingSegment			1
Number of reporting segments | ReportingSegment			1
Revenues	$ 2,134	$ 1,540	$ 4,238		$ 3,900
Period for which the convertible debt must remain outstanding for an emerging growth company to become a large accelarated filer			3 years
Class of warrants or rights outstanding | shares	2,680,607		2,680,607				2,680,596
Change in fair value of earn-out liability	$ 6,566	0	$ 12,557	[1]	0
Offering costs incurred	800	$ 0	$ 800		$ 0
Service Based And Performance Based Restricted Stock Units [Member] | 2013 Equity Incentive Plan
Summary Of Significant Accounting Policies [Line Items]
Share based compensation by share based award requisite service period			4 years
Sponsor [Member]
Summary Of Significant Accounting Policies [Line Items]
Period of earnout shares			5 years
Sponsor [Member] | Earnout Liability [Member]
Summary Of Significant Accounting Policies [Line Items]
Business combination contingent consideration liability at fair value	$ 7,900		$ 7,900			$ 20,400
Private Placement Warrants [Member]
Summary Of Significant Accounting Policies [Line Items]
Class of warrants or rights outstanding | shares	4,450,000		4,450,000
Class of warrants or rights exercise price of warrants or rights | $ / shares	$ 11.5		$ 11.5
Class of warrants or rights maturity period	5 years		5 years
Derivative liabilities	$ 9,600		$ 9,600
Financial liabilities at fair value	$ 6,500		$ 6,500
Public Warrants [Member]
Summary Of Significant Accounting Policies [Line Items]
Class of warrants or rights outstanding | shares	8,625,000		8,625,000
Class of warrants or rights exercise price of warrants or rights | $ / shares	$ 11.5		$ 11.5
Class of warrants or rights maturity period	5 years		5 years
Derivative liabilities	$ 16,300		$ 16,300
Financial liabilities at fair value	$ 5,600		$ 5,600
Public Warrants [Member] | Number Of Shares Which The Warrant Holders Are Entiled To Exercise Per Share In Case Effective Registration Statement Is Not Filed [Member]
Summary Of Significant Accounting Policies [Line Items]
Class of warrants or rights number of securities covered by each warrant or right | shares	0.361		0.361
Revenue from Rights Concentration Risk [Member] | Revenue [Member]
Summary Of Significant Accounting Policies [Line Items]
Concentration Risk, Percentage	100%	100%	100%		100%
Revenue from Rights Concentration Risk [Member] | Revenue [Member] | Government Entities [Member]
Summary Of Significant Accounting Policies [Line Items]
Concentration Risk, Percentage	67.80%	69.70%	72%		74.90%
Maximum [Member] | Share-based Payment Arrangement, Option [Member]
Summary Of Significant Accounting Policies [Line Items]
Share based compensation by share based award requisite service period			5 years
Minimum [Member] | Share-based Payment Arrangement, Option [Member]
Summary Of Significant Accounting Policies [Line Items]
Share based compensation by share based award requisite service period			1 year
Minimum [Member] | Condition For An Emerging Growth Company To Become A Large Accelarated Filer [Member]
Summary Of Significant Accounting Policies [Line Items]
Revenues			$ 1,070,000
Public float	$ 700,000		700,000
Convertible debt	$ 1,000,000		$ 1,000,000
[1]For discussion on the restatement adjustments, see Note 1 — Description of Business — Restatement of Condensed Consolidated Financial Statements and Immaterial Correction of Prior-Period Errors

Summary of Significant Accoun_5

Summary of Significant Accounting Policies - Summary of Cash Cash Equivalents and Short Term Investments (Detail) - USD ($) $ in Thousands	Jun. 30, 2022	Dec. 31, 2021
Cash	$ 184,020	$ 11,729
Restricted cash	117	317
Total cash and restricted cash	$ 184,137	$ 12,046

Summary of Significant Accoun_6

Summary of Significant Accounting Policies - Summary Of Earnings Per Share Basic And Diluted (Detail) - Customer Concentration Risk [Member] - Revenue Benchmark [Member]	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Customer A [Member]
Schedule of Transition Period Comparative Data line items [Line Items]
Concentration Risk, Percentage	32%	30%	33%
Customer B [Member]
Schedule of Transition Period Comparative Data line items [Line Items]
Concentration Risk, Percentage	22%	64%	28%	25%
Customer C [Member]
Schedule of Transition Period Comparative Data line items [Line Items]
Concentration Risk, Percentage	19%		16%	30%
Customer D [Member]
Schedule of Transition Period Comparative Data line items [Line Items]
Concentration Risk, Percentage	19%		10%
Customer E [Member]
Schedule of Transition Period Comparative Data line items [Line Items]
Concentration Risk, Percentage				36%

Summary of Significant Accoun_7

Summary of Significant Accounting Policies - Schedule of Inputs Into the Respective Models (Detail)		Jun. 30, 2022 shares yr	Mar. 02, 2022 shares yr
Stock Price
Disclosure In Tabular Form Of Assumptions Based On Significant Unobservable Inputs Used In The Valuation Of Earn out Liability Arising Out Of Business Combination [Line Items]
Valuation Assumptions		3.67	9.43
Simulated trading days
Disclosure In Tabular Form Of Assumptions Based On Significant Unobservable Inputs Used In The Valuation Of Earn out Liability Arising Out Of Business Combination [Line Items]
Valuation Assumptions		1,177	1,198
Volatility
Disclosure In Tabular Form Of Assumptions Based On Significant Unobservable Inputs Used In The Valuation Of Earn out Liability Arising Out Of Business Combination [Line Items]
Valuation Assumptions	[1]	79.2	30.5
Risk-free Rate
Disclosure In Tabular Form Of Assumptions Based On Significant Unobservable Inputs Used In The Valuation Of Earn out Liability Arising Out Of Business Combination [Line Items]
Valuation Assumptions		2.98	1.74
Estimated time to expiration
Disclosure In Tabular Form Of Assumptions Based On Significant Unobservable Inputs Used In The Valuation Of Earn out Liability Arising Out Of Business Combination [Line Items]
Valuation Assumptions | yr		4.67	5
[1]As restated and discussed in Note 1 — Description of Business — Restatement of Condensed Consolidated Financial Statements and Immaterial Correction of Prior-Period Errors

Summary of Significant Accoun_8

Summary of Significant Accounting Policies - Schedule of Customers Accounts Receivable (Detail) - Customer Concentration Risk [Member] - Accounts Receivable [Member]	6 Months Ended	12 Months Ended
	Jun. 30, 2022	Dec. 31, 2021
Customer A [Member]
Disclosure In Tabular Form Of Concentration Of Accounts Recievable [Line Items]
Concentration Risk, Percentage	25%	35%
Customer B [Member]
Disclosure In Tabular Form Of Concentration Of Accounts Recievable [Line Items]
Concentration Risk, Percentage	24%	34%
Customer C [Member]
Disclosure In Tabular Form Of Concentration Of Accounts Recievable [Line Items]
Concentration Risk, Percentage	16%	29%
Customer D [Member]
Disclosure In Tabular Form Of Concentration Of Accounts Recievable [Line Items]
Concentration Risk, Percentage	16%
Customer E [Member]
Disclosure In Tabular Form Of Concentration Of Accounts Recievable [Line Items]
Concentration Risk, Percentage	11%

Business Combination - Summary

Business Combination - Summary of Consummation of the Business Combination (Parenthetical) (Detail)	Jun. 30, 2022 shares
Disclosure In Tabular Form Of Reconciliation Of Common Stock Shares Issued Following Business Combination [Line Items]
Shares outstanding	113,810,285
Common stock shares exchange ratio	0.787
Series C Redeemable Convertible Preferred Stock [Member]
Disclosure In Tabular Form Of Reconciliation Of Common Stock Shares Issued Following Business Combination [Line Items]
Conversion from temporary equity to permanent equity exchange ratio	1
Series C One Redeemable Convertible Preferred Stock [Member]
Disclosure In Tabular Form Of Reconciliation Of Common Stock Shares Issued Following Business Combination [Line Items]
Conversion from temporary equity to permanent equity exchange ratio	8
Promote Sponsor Vesting Shares [Member]
Disclosure In Tabular Form Of Reconciliation Of Common Stock Shares Issued Following Business Combination [Line Items]
Shares outstanding	2,479,000
Sponsor Redemption Based Vesting Shares [Member]
Disclosure In Tabular Form Of Reconciliation Of Common Stock Shares Issued Following Business Combination [Line Items]
Shares outstanding	580,273

Business Combination - Addition

Business Combination - Additional Information (Detail) $ / shares in Units, $ in Thousands			3 Months Ended	6 Months Ended
	Jun. 30, 2022 $ / shares shares	Mar. 02, 2022 shares	Jun. 30, 2022 USD ($) $ / shares shares	Jun. 30, 2022 USD ($) $ / shares shares		Jun. 30, 2021 USD ($)	Dec. 31, 2021 $ / shares shares	Dec. 23, 2021 USD ($) $ / shares shares	Dec. 01, 2021 USD ($) $ / shares shares
Business Acquisition, Contingent Consideration [Line Items]
Common stock shares authorized | shares	1,000,000,000	1,000,000,000	1,000,000,000	1,000,000,000			134,050,472
Preferred stock shares authorized | shares	10,000,000	10,000,000	10,000,000	10,000,000			0
Common stock par or stated value per share	$ 0.0001		$ 0.0001	$ 0.0001			$ 0.0001
Common stock number of votes per share	1		1	1
Preferred stock, shares issued | shares	0		0	0			0
Preferred stock, Outstanding | shares	0		0	0			0
Preferred stock par or stated value per share	$ 0.0001		$ 0.0001	$ 0.0001			$ 0.0001
Class of warrants or rights outstanding exercise price per share of the resulting company due to business combination	11.5		11.5	11.5
Class of warrants or rights number of shares covered by each warrant or right in the resulting company due to business combination	1		1	1
Temporary equity of previous company converted into permanent equity of the resultant company par or stated value per share	$ 0.000001		$ 0.000001	$ 0.000001
Common stock shares exchange ratio	0.787		0.787	0.787
Common stock shares issued as a result of exchange | shares	78,959,579		78,959,579	78,959,579
Number of trading days for determining the share price	20 days	20 days
Proceeds from Business Combination, net of transaction costs paid | $				$ 225,604	[1]	$ 0
One-time bonus | $			$ 0	2,100
Sponsor Agreement [Member]
Business Acquisition, Contingent Consideration [Line Items]
Proceeds from Business Combination, net of transaction costs paid | $				$ 19,750
Common Class A [Member]
Business Acquisition, Contingent Consideration [Line Items]
Common stock of previous company converted into current company common stock par or stated value per share	$ 0.0001		$ 0.0001	$ 0.0001
Common Class B [Member]
Business Acquisition, Contingent Consideration [Line Items]
Common stock of previous company converted into current company common stock par or stated value per share	$ 0.0001		$ 0.0001	$ 0.0001
Supernova Acquistion [Member] | Sponsor Agreement [Member] | Tranche One [Member]
Business Acquisition, Contingent Consideration [Line Items]
Shares subject to vesting | shares	2,479,000		2,479,000	2,479,000
Volume weighted average price per share	$ 12.5
Shares subject to vesting maximum period	5 years
Number of consecutive trading days for determining the share price	30 days
Supernova Acquistion [Member] | Sponsor Agreement [Member] | Tranche Two [Member]
Business Acquisition, Contingent Consideration [Line Items]
Shares subject to vesting | shares	580,273		580,273	580,273
Volume weighted average price per share	$ 15
Shares subject to vesting maximum period	5 years
Number of consecutive trading days for determining the share price	30 days
Supernova Acquistion [Member] | Initial Subscription Agreement [Member] | Private Investment In Public Equity Investors [Member]
Business Acquisition, Contingent Consideration [Line Items]
Common stock shares subscribed but not issued | shares									10,251,000
Shares issued price per share									$ 10
Common stock shares subscribed but not issued value | $									$ 102,500
Supernova Acquistion [Member] | Subsequent Subscription Agreement [Member] | Private Investment In Public Equity Investors [Member]
Business Acquisition, Contingent Consideration [Line Items]
Common stock shares subscribed but not issued | shares								4,390,244
Shares issued price per share								$ 10.25
Common stock shares subscribed but not issued value | $								$ 45,000
[1]For discussion on the restatement adjustments, see Note 1 — Description of Business — Restatement of Condensed Consolidated Financial Statements and Immaterial Correction of Prior-Period Errors

Business Combination - Summar_2

Business Combination - Summary of Net proceeds from Business Combination and PIPE financing (Detail) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2022		Jun. 30, 2021
Disclosure In Tabular Form Of Net Proceeds From Business Combination [Line Items]
Cash - SNII trust and cash (net of redemption)	$ 77,769
Cash - PIPE	147,510
Cash - SNII operating account	325
Net Proceeds from Business Combination and PIPE	$ 225,604	[1]	$ 0
[1]For discussion on the restatement adjustments, see Note 1 — Description of Business — Restatement of Condensed Consolidated Financial Statements and Immaterial Correction of Prior-Period Errors

Business Combination - Summar_3

Business Combination - Summary of Net proceeds from Business Combination and PIPE financing (Parenthetical) (Detail) - USD ($) $ in Thousands	3 Months Ended	6 Months Ended
	Jun. 30, 2022	Jun. 30, 2022		Jun. 30, 2021	Dec. 31, 2021
Disclosure In Tabular Form Of Net Proceeds From Business Combination [Line Items]
Business combination transaction costs					$ 20,650
Adjustment to additional paid in capital business combination transaction costs		$ 19,750
Business combination transaction costs expensed		900
Payment of transaction costs through cash	$ 0	16,700
Adjustment to additional paid in combination business combination proceed net of transaction costs		159,550
Proceeds from business combination net of transaction costs paid		225,604	[1]	$ 0
Adjustment to additional paid in capital earnout liabilities		20,400
Public Warrants [Member]
Disclosure In Tabular Form Of Net Proceeds From Business Combination [Line Items]
Adjustment to additional paid in capital adjustment for warrant liabilities		16,300
Private Warrants [Member]
Disclosure In Tabular Form Of Net Proceeds From Business Combination [Line Items]
Adjustment to additional paid in capital adjustment for warrant liabilities		$ 9,600
[1]For discussion on the restatement adjustments, see Note 1 — Description of Business — Restatement of Condensed Consolidated Financial Statements and Immaterial Correction of Prior-Period Errors

Business Combination - Summar_4

Business Combination - Summary of Consummation of the Business Combination (Detail)	6 Months Ended
	Jun. 30, 2022 shares
Disclosure In Tabular Form Of Reconciliation Of Common Stock Shares Issued Following Business Combination [Line Items]
Shares issued in PIPE	14,641,244
Business Combination and PIPE shares	34,850,706
Common stock—Legacy Rigetti	18,221,069	[1]
Common stock—exercise of Legacy Rigetti stock options immediately prior to the closing	1,123,539	[1]
Common stock—exercise of Legacy Rigetti warrants immediately prior to the closing	2,234,408	[1]
Ending balance, shares	113,810,285
Common Class A [Member] | Status Of Shares Outstanding Before Business Combination [Member]
Disclosure In Tabular Form Of Reconciliation Of Common Stock Shares Issued Following Business Combination [Line Items]
Beginning balance, shares	34,500,000
Less: redemption of SNII Class A ordinary shares	(22,915,538)
Common Stock — SNII Class ordinary shares	11,584,462
Common Class B [Member]
Disclosure In Tabular Form Of Reconciliation Of Common Stock Shares Issued Following Business Combination [Line Items]
Common Stock — SNII Class ordinary shares	8,625,000	[2]
Series C Redeemable Convertible Preferred Stock [Member]
Disclosure In Tabular Form Of Reconciliation Of Common Stock Shares Issued Following Business Combination [Line Items]
Common stock—upon conversion of Legacy Rigetti Series preferred stock	54,478,261	[1]
Series C One Redeemable Convertible Preferred Stock [Member]
Disclosure In Tabular Form Of Reconciliation Of Common Stock Shares Issued Following Business Combination [Line Items]
Common stock—upon conversion of Legacy Rigetti Series preferred stock	2,902,302	[1]
[1](i) all outstanding shares of Legacy Rigetti Common Stock as of immediately prior to the Closing (including Legacy Rigetti Common Stock resulting from the Legacy Rigetti Preferred Stock Conversion), were exchanged at an exchange ratio of 0.7870 (the “Exchange Ratio”). (ii) the conversion ratio to Legacy Rigetti Common Stock for the Legacy Series C Preferred Stock was one-for-one and for Legacy Series C-1 Preferred Stock was eight-for-one.[2]Includes (i) 2,479,000 shares of Common Stock held by the Sponsor (the “Promote Sponsor Vesting Shares”) and (ii) 580,273 shares of Common Stock held by the Sponsor (“Sponsor Redemption-Based Vesting Shares”).

Revenue Recognition - Additiona

Revenue Recognition - Additional Information (Details) $ in Millions	Jun. 30, 2022 USD ($)
Disaggregation of Revenue [Line Items]
Transaction price allocated to remaining performance obligations	$ 9.5
Remainder Of Two Thousand And Twenty Two [Member]
Disaggregation of Revenue [Line Items]
Transaction price allocated to remaining performance obligations	3.8
2023 [Member]
Disaggregation of Revenue [Line Items]
Transaction price allocated to remaining performance obligations	$ 5.7

Revenue Recognition - Summary o

Revenue Recognition - Summary of Disaggregation of Revenue (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Disaggregation of Revenue [Line Items]
Revenue	$ 2,134	$ 1,540	$ 4,238	$ 3,900
Revenue recognized at a point in time [Member]
Disaggregation of Revenue [Line Items]
Revenue	0	0	0	0
Revenue recognized over time [Member]
Disaggregation of Revenue [Line Items]
Revenue	2,134	1,540	4,238	3,900
Collaborative research and other professional services [Member]
Disaggregation of Revenue [Line Items]
Revenue	1,477	944	2,992	2,547
Access to quantum computing systems [Member]
Disaggregation of Revenue [Line Items]
Revenue	$ 657	$ 596	$ 1,246	$ 1,353

Revenue Recognition - Summary_2

Revenue Recognition - Summary of Contract with Customer, Contract Asset, Contract Liability, and Receivable (Details) - USD ($) $ in Thousands	Jun. 30, 2022	Dec. 31, 2021
Capitalized Contract Cost [Line Items]
Trade receivables, net	$ 2,350	$ 961
Unbilled receivables	222	582
Deferred revenue - current	$ (1,108)	$ (985)

Revenue Recognition - Summary_3

Revenue Recognition - Summary of Change in Contract with Customer, Asset and Liability (Details) $ in Thousands	6 Months Ended
	Jun. 30, 2022 USD ($)
Capitalized Contract Cost [Line Items]
Balance at beginning of period	$ (985)
Deferral of revenue	(673)
Recognition of deferred revenue	550
Balance at end of period	$ (1,108)

Commitments and Contingencies -

Commitments and Contingencies - Summary Of Lessee Operating Lease Liability Maturity (Detail) - Rigetti Holdings Inc [Member] $ in Thousands	Jun. 30, 2022 USD ($)
Remainder of 2022	$ 879
2023	1,262
2024	1,299
2025	1,338
2026	1,379
Thereafter	4,006
Total minimum future lease payments	$ 10,163

Commitments and Contingencies_2

Commitments and Contingencies - Additional Information (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021	Dec. 31, 2021
Straight Line Rent Adjustments	$ 0.5	$ 0.4	$ 1	$ 0.8
Deferred Rent Credit, Current	$ 0.4		$ 0.4		$ 0.4

Financing Arrangements - Schedu

Financing Arrangements - Scheduled principal payments on total outstanding debt (Detail) - USD ($) $ in Thousands	Jun. 30, 2022	Dec. 31, 2021
2022	$ 702	$ 702
2023	9,273	8,682
2024	12,914	11,008
2025	8,734	6,608
2026	377	0
Loan payable, long term	$ 32,000	$ 27,000

Financing Arrangements - Long

Financing Arrangements - Long term debt and the unamortized discount (Detail) - USD ($) $ in Thousands	Jun. 30, 2022	Dec. 31, 2021	May 31, 2021
Outstanding principal amount	$ 32,000	$ 27,000
Add: accreted liability of final payment fee	256	125
Less: unamortized debt discount, long term	(2,117)	(1,618)	$ (2,800)
Less: current portion of long term debt principal	(4,938)	(1,291)
Debt-net of current portion	25,201	24,216
Current portion of long term debt - principal	4,938	1,291
Less: current portion of unamortized debt discount	(712)	(716)
Debt—current portion	$ 4,226	$ 575

Financing Arrangements - Additi

Financing Arrangements - Additional Information (Detail) - USD ($)			3 Months Ended	6 Months Ended
	Jan. 31, 2022	May 31, 2021	Jun. 30, 2022	Jun. 30, 2022		Jun. 30, 2021	Jun. 02, 2022	Dec. 31, 2021	Mar. 31, 2021
Line of Credit Facility [Line Items]
Debt issuance costs		$ 2,800,000	$ 2,117,000	$ 2,117,000				$ 1,618,000
Amortization of debt issuance cost				$ 667,000	[1]	$ 0
Common Stock warrants [Member]
Line of Credit Facility [Line Items]
Class of warrants issued during period							783,129
Class of Warrant or Right, Number of Securities Called by Warrants or Rights			(783,129)	(783,129)					(313,252)
Loan and Security Agreement [Member]
Line of Credit Facility [Line Items]
Debt Instrument, Interest Rate, Stated Percentage		11%
Debt instrument payment fee, Percentage		2.75%
Interest expense			$ 1,200,000	$ 2,400,000
Accretion Expense			88,900	134,800
Debt Related Commitment Fees			68,000	116,300
Amortization of debt issuance cost			179,700	415,600
unamortized issuance cost			$ 2,800,000	$ 2,800,000
Debt Instrument, Frequency of Periodic Payment		payable monthly
Loan and Security Agreement [Member] | Prime Rate [Member]
Line of Credit Facility [Line Items]
Debt Instrument, Description of Variable Rate Basis		US Prime Rate plus 7.50% per annum
Debt Instrument, Variable Rate		7.50%
Loan and Security Agreement [Member] | Maximum [Member]
Line of Credit Facility [Line Items]
Debt Instrument, Interest Rate, Stated Percentage			23.70%	23.70%
Loan and Security Agreement [Member] | Minimum [Member]
Line of Credit Facility [Line Items]
Debt Instrument, Interest Rate, Stated Percentage			17.83%	17.83%
Tranche A [Member] | Loan and Security Agreement [Member] | Venture Capital [Member]
Line of Credit Facility [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity									$ 12,000,000
Tranche B [Member] | Loan and Security Agreement [Member] | Venture Capital [Member]
Line of Credit Facility [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity		$ 15,000,000
Line of Credit Facility, Current Borrowing Capacity		8,000,000
Line of Credit Facility, Remaining Borrowing Capacity		7,000,000
Withdrawn Credit Facility		$ 7,000,000
Class of warrants issued during period		995,099
Tranche B [Member] | Loan and Security Agreement [Member] | Maximum [Member] | Venture Capital [Member]
Line of Credit Facility [Line Items]
Debt Instrument, Term		48 months
Tranche B [Member] | Loan and Security Agreement [Member] | Minimum [Member] | Venture Capital [Member]
Line of Credit Facility [Line Items]
Debt Instrument, Term		19 months
Tranche C [Member]
Line of Credit Facility [Line Items]
Debt Instrument, Interest Rate, Stated Percentage	11%
Debt Related Commitment Fees	$ 1,000,000
Debt Instrument, Face Amount	$ 5,000,000
Debt Instrument, Payment Terms	19 months
Debt Instrument, Frequency of Periodic Payment	payable monthly
Debt Instrument, Maturity Date	Feb. 01, 2026
Percentage of debt related cost paid upon the consummation of merger	20
Debt instrument, repurchase amount	$ 75,000,000
Debt instrument, fee amount	$ 5,000,000
Tranche C [Member] | Prime Rate [Member]
Line of Credit Facility [Line Items]
Debt Instrument, Description of Variable Rate Basis	US Prime Rate plus 7.50% per annum
Debt Instrument, Variable Rate	7.50%
[1]For discussion on the restatement adjustments, see Note 1 — Description of Business — Restatement of Condensed Consolidated Financial Statements and Immaterial Correction of Prior-Period Errors

Redeemable Convertible Prefer_2

Redeemable Convertible Preferred Stock - Additional Information (Detail) - $ / shares	Jun. 30, 2022	Mar. 02, 2022	Dec. 31, 2021
Temporary Equity [Line Items]
Preferred stock, authorized	10,000,000	10,000,000	0
Preferred stock, par value	$ 0.0001		$ 0.0001
Series C Preferred Stock [Member]
Temporary Equity [Line Items]
Preferred stock, authorized	73,389,000
Series C-1 Preferred Stock [Member]
Temporary Equity [Line Items]
Preferred stock, authorized	62,537,577
Preferred Stock [Member]
Temporary Equity [Line Items]
Preferred stock, par value	$ 0.000001

Common Stock - Summary of Conve

Common Stock - Summary of Conversions of Stock (Detail)	Jun. 30, 2022 shares
Conversion of Stock [Line Items]
Common Stock, Capital Shares Reserved for Future Issuance	39,459,251
Stock-Based Awards - Options Outstanding
Conversion of Stock [Line Items]
Common Stock, Capital Shares Reserved for Future Issuance	9,482,711
Stock-Based Awards - RSUs Outstanding
Conversion of Stock [Line Items]
Common Stock, Capital Shares Reserved for Future Issuance	11,850,526
Common Stock Warrants
Conversion of Stock [Line Items]
Common Stock, Capital Shares Reserved for Future Issuance	18,126,014

Common Stock - Additional Infor

Common Stock - Additional Information (Detail) - shares	6 Months Ended
	Jun. 30, 2022	Mar. 02, 2022	Dec. 31, 2021
Conversion of Stock [Line Items]
Common Stock, Shares Authorized	1,000,000,000	1,000,000,000	134,050,472
Common Stock, Voting Rights	one vote
Preferred stock, authorized	10,000,000	10,000,000	0
Preferred stock, shares issued	0		0
Preferred stock, Outstanding	0		0

Warrants - Additional Informati

Warrants - Additional Information (Details)

3 Months Ended

6 Months Ended

Jun. 30, 2022 USD ($) $ / shares shares

Mar. 02, 2022

Jun. 30, 2022 USD ($) $ / shares shares

Jun. 30, 2021 USD ($)

Jun. 30, 2022 USD ($) $ / shares shares

Jun. 30, 2021 USD ($)

Jun. 02, 2022 USD ($) shares

Dec. 31, 2021 shares

Mar. 31, 2021 shares

Jan. 31, 2021 $ / shares shares

Feb. 28, 2020 USD ($)

Class Of Warrant Or Right [Line Items]

Warrants outstanding | shares

2,680,607

2,680,607

2,680,607

2,680,596

Change in fair value of derivative warrant liabilities | $

$ (7,980,000)

$ 0

$ (11,750,000)

[1]

$ 0

Adjustment to additional paid in capital warrants issued | $

$ 1,200,000

Share price | $ / shares

$ 0.01

$ 0.01

$ 0.01

Number of trading days for determining the share price

20 days

20 days

Fair value of warrant liability prior to exercise reclassified to equity | $

$ 6,400,000

Warrant liability outstanding | $

$ 6,400,000

Public Warrants

Class Of Warrant Or Right [Line Items]

Warrants outstanding | shares

8,625,000

8,625,000

8,625,000

Exercise price of warrants | $ / shares

$ 11.5

$ 11.5

$ 11.5

Warrants and rights outstanding, term

5 years

5 years

5 years

Share price | $ / shares

$ 18

$ 18

$ 18

Number of trading days for determining the share price

20 days

Number of consecutive trading days for determining the share price

30 days

Waiting period after which the share trading days are considered

30 days

Private Placement

Class Of Warrant Or Right [Line Items]

Warrants outstanding | shares

4,450,000

4,450,000

4,450,000

Common Stock Warrants

Class Of Warrant Or Right [Line Items]

Class of Warrant or Right, Number of Securities Called by Each Warrant or Right | shares

783,129

Change in fair value of derivative warrant liabilities | $

$ 1,500,000

$ 2,000,000

Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares

783,129

783,129

783,129

313,252

Common Stock Warrants | Class A Ordinary Shares

Class Of Warrant Or Right [Line Items]

Class of warrant or right, Grand date fair value | $

$ 200,000

Warrants To Purchase Class A Common Stock [Member] | Series C Redeemable Convertible Preferred Stock [Member]

Class Of Warrant Or Right [Line Items]

Exercise price of warrants | $ / shares

$ 0.01

$ 0.01

$ 0.01

Class of warrants or rights warrants issued during the period units | shares

5,248,183

Warrants and rights outstanding, term

10 years

10 years

10 years

Customer Warrants [Member] | Class A Ordinary Shares

Class Of Warrant Or Right [Line Items]

Exercise price of warrants | $ / shares

$ 1.152

Warrants and rights outstanding, term

10 years

Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares

2,680,607

Deferred asset reduction of revenue | $

$ 2,400

$ 3,900

Deferred assets in connection with warrants issued to customer | $

$ 91,200

$ 91,200

$ 91,200

Customer Warrants [Member] | Class A Ordinary Shares | Maximum [Member]

Class Of Warrant Or Right [Line Items]

Class Of Warrants Vesting Percentage

100

Customer Warrants [Member] | Class A Ordinary Shares | Minimum [Member]

Class Of Warrant Or Right [Line Items]

Class Of Warrants Vesting Percentage

50

Trinity Warrants [Member]

Class Of Warrant Or Right [Line Items]

Class Of Warrant Or Right Issued During Period Warrants | shares

469,877

Class of Warrants or Rights Aggregate Fair Value of Warrants at the Time of Grant | $

$ 2,700,000

Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares

783,129

783,129

783,129

[1]For discussion on the restatement adjustments, see Note 1 — Description of Business — Restatement of Condensed Consolidated Financial Statements and Immaterial Correction of Prior-Period Errors

Warrants - Schedule Of Fair Val

Warrants - Schedule Of Fair Value Of The Private Placement Warrant Measured Using Black Scholes Approach (Details)		Jun. 30, 2022 yr	Jun. 02, 2022 yr	Mar. 02, 2022 yr
Measurement Input, Share Price [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and rights outstanding, measurement input			8.23
Measurement Input, Share Price [Member] | Private Warrant [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and rights outstanding, measurement input	[1]	3.67
Measurement Input, Exercise Price [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and rights outstanding, measurement input			0.27
Measurement Input, Exercise Price [Member] | Private Warrant [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and rights outstanding, measurement input	[1]	11.5
Measurement Input, Price Volatility [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and rights outstanding, measurement input			105.1
Measurement Input, Price Volatility [Member] | Private Warrant [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and rights outstanding, measurement input	[1]	0.7903
Measurement Input, Risk Free Interest Rate [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and rights outstanding, measurement input			2.94
Measurement Input, Risk Free Interest Rate [Member] | Private Warrant [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and rights outstanding, measurement input	[1]	0.0301
Measurement Input, Expected Term [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and rights outstanding, measurement input			9
Measurement Input, Expected Term [Member] | Private Warrant [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and rights outstanding, measurement input	[1]	4.672
Measurement Input, Expected Dividend Rate [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and rights outstanding, measurement input			0
Measurement Input, Expected Dividend Rate [Member] | Private Warrant [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and rights outstanding, measurement input	[1]	0
AtInitialRecognition [Member] | Measurement Input, Share Price [Member] | Private Warrant [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and rights outstanding, measurement input	[1]			9.43
AtInitialRecognition [Member] | Measurement Input, Exercise Price [Member] | Private Warrant [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and rights outstanding, measurement input	[1]			11.5
AtInitialRecognition [Member] | Measurement Input, Price Volatility [Member] | Private Warrant [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and rights outstanding, measurement input	[1]			0.3066
AtInitialRecognition [Member] | Measurement Input, Risk Free Interest Rate [Member] | Private Warrant [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and rights outstanding, measurement input	[1]			0.0174
AtInitialRecognition [Member] | Measurement Input, Expected Term [Member] | Private Warrant [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and rights outstanding, measurement input	[1]			5
AtInitialRecognition [Member] | Measurement Input, Expected Dividend Rate [Member] | Private Warrant [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and rights outstanding, measurement input	[1]			0
[1]As restated and discussed in Note 1 — Description of Business — Restatement of Condensed Consolidated Financial Statements and Immaterial Correction of Prior-Period Errors

Warrants - Schedule Of Fair V_2

Warrants - Schedule Of Fair Value Of The Trinity Warrant liabilities Measured Using Black Scholes Approach (Details)	Jun. 02, 2022 yr
Measurement Input, Share Price [Member]
Class of Warrant or Right [Line Items]
Warrants and rights outstanding, measurement input	8.23
Measurement Input, Exercise Price [Member]
Class of Warrant or Right [Line Items]
Warrants and rights outstanding, measurement input	0.27
Measurement Input, Price Volatility [Member]
Class of Warrant or Right [Line Items]
Warrants and rights outstanding, measurement input	105.1
Measurement Input, Risk Free Interest Rate [Member]
Class of Warrant or Right [Line Items]
Warrants and rights outstanding, measurement input	2.94
Measurement Input, Expected Term [Member]
Class of Warrant or Right [Line Items]
Warrants and rights outstanding, measurement input	9
Measurement Input, Expected Dividend Rate [Member]
Class of Warrant or Right [Line Items]
Warrants and rights outstanding, measurement input	0

Warrants - Summary of Vesting S

Warrants - Summary of Vesting Status of the Customer Warrant (Details) - shares	Jun. 30, 2022	Dec. 31, 2021
Disclosure Of Vesting Status Of Warrants [Line Items]
Warrants outstanding	2,680,607	2,680,596
Vested Customer Warrants [Member]
Disclosure Of Vesting Status Of Warrants [Line Items]
Warrants outstanding	1,072,237	1,072,237
Unvested Customer Warrants [Member]
Disclosure Of Vesting Status Of Warrants [Line Items]
Warrants outstanding	1,608,370	1,608,359

Forward Warrant Agreement - Add

Forward Warrant Agreement - Additional Information (Detail) - Forward Warrant Agreement [Member] - USD ($) $ / shares in Units, $ in Millions		6 Months Ended	12 Months Ended
	Jun. 30, 2022	Jun. 30, 2022	Dec. 31, 2021	Jun. 30, 2021
Rigetti [Member]
Class of Warrant or Right [Line Items]
Derivative liabilities	$ 0.2	$ 0.2
Derivative asset	1.5	1.5
Ampere
Class of Warrant or Right [Line Items]
Business combination consideration to be paid	$ 5
Share based compensation arrangement share based payment award options vested and exercisable				500,000
Ampere | Rigetti [Member]
Class of Warrant or Right [Line Items]
Proceeds from Issuance of Warrants		$ 10
Stock issued during period number of warrants issued		1,000,000
Exercise price of warrants	$ 0.0001	$ 0.0001
Ampere | Rigetti [Member] | Share-based Payment Arrangement, Tranche One [Member]
Class of Warrant or Right [Line Items]
Business combination consideration to be paid	$ 5		$ 5
Share based compensation arrangement share based payment award options vested and exercisable	500,000	500,000
Ampere | Rigetti [Member] | Share-based Payment Arrangement, Tranche Two [Member]
Class of Warrant or Right [Line Items]
Business combination consideration to be paid	$ 5
Share based compensation arrangement share based payment award options vested and exercisable	500,000	500,000

Forward Warrant Agreement - Sum

Forward Warrant Agreement - Summary of Fair Value Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques (Detail) - Forward Warrant Agreement [Member]	Jun. 30, 2022 yr
Measurement Input, Expected Term [Member] | Maximum [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative Liability, Measurement Input	0.628
Measurement Input, Expected Term [Member] | Minimum [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative Liability, Measurement Input	0
Measurement Input, Risk Free Interest Rate [Member] | Maximum [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative Liability, Measurement Input	0.0257
Measurement Input, Risk Free Interest Rate [Member] | Minimum [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative Liability, Measurement Input	0
Measurement Input Probability Of Occurring The Contingency [Member] | Maximum [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative Liability, Measurement Input	1
Measurement Input Probability Of Occurring The Contingency [Member] | Minimum [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative Liability, Measurement Input	0.50
Measurement Input, Share Price [Member] | Maximum [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative Liability, Measurement Input	3.67
Measurement Input, Share Price [Member] | Minimum [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative Liability, Measurement Input	3.39

Fair Value Measurements - Summa

Fair Value Measurements - Summary of Information About Assets and Liabilities Measured at Fair Value on Recurring Basis (Details) - USD ($) $ in Thousands		Jun. 30, 2022		Dec. 31, 2021
Fair Value, Inputs, Level 1
Assets:
Forward Warrant Agreement		$ 0
Total assets		0
Liabilities:
Derivative liabilities		5,606	[1]	$ 0
Fair Value, Inputs, Level 2
Assets:
Forward Warrant Agreement		0
Total assets		0
Liabilities:
Derivative liabilities		0	[1]	0
Fair Value, Inputs, Level 2 | Earn out Liability [Member]
Liabilities:
Earn-out Liability	[1]	0
Fair Value, Inputs, Level 3
Assets:
Forward Warrant Agreement	[1]	1,543
Total assets	[1]	1,543
Liabilities:
Derivative liabilities		14,398	[1]	4,585
Fair Value, Inputs, Level 3 | Earn out Liability [Member]
Liabilities:
Earn-out Liability	[1]	7,856
Public Warrants | Fair Value, Inputs, Level 1 | Derivative
Liabilities:
Derivative liabilities		5,606
Public Warrants | Fair Value, Inputs, Level 2 | Derivative
Liabilities:
Derivative liabilities		0
Public Warrants | Fair Value, Inputs, Level 3 | Derivative
Liabilities:
Derivative liabilities	[1]	0
Trinity Warrants | Fair Value, Inputs, Level 2 | Derivative
Liabilities:
Derivative liabilities				0
Trinity Warrants | Fair Value, Inputs, Level 3 | Derivative
Liabilities:
Derivative liabilities				4,355
Private Warrants | Fair Value, Inputs, Level 1 | Derivative
Liabilities:
Derivative liabilities	[1]	0
Private Warrants | Fair Value, Inputs, Level 2 | Derivative
Liabilities:
Derivative liabilities	[1]	0
Private Warrants | Fair Value, Inputs, Level 3 | Derivative
Liabilities:
Derivative liabilities	[1]	$ 6,542
Forward warrant agreement | Fair Value, Inputs, Level 1 | Derivative
Liabilities:
Derivative liabilities				0
Forward warrant agreement | Fair Value, Inputs, Level 2 | Derivative
Liabilities:
Derivative liabilities				0
Forward warrant agreement | Fair Value, Inputs, Level 3 | Derivative
Liabilities:
Derivative liabilities				$ 230
[1]For discussion on the restatement adjustments, see Note 1 — Description of Business — Restatement of Condensed Consolidated Financial Statements and Immaterial Correction of Prior-Period Errors

Fair Value Measurements - Sum_2

Fair Value Measurements - Summary Of Change in Fair Value of Derivative Liabilities (Detail) - Fair Value, Inputs, Level 3 $ in Thousands	6 Months Ended
	Jun. 30, 2022 USD ($)
Forward Warrant Agreement [Member]
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]
Balance—December 31, 2021	$ 230
Change in fair values	(5,078)	[1]
Extinguishment due to exercise of the warrants	3,305
Balance—June 30, 2022	(1,543)	[1]
Earn out Liability [Member]
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]
Balance—December 31, 2021	0
Initial measurement on March 2, 2022 upon Business Combination (Note 3)	20,413
Change in fair values	(12,557)	[1]
Extinguishment due to exercise of the warrants	0
Balance—June 30, 2022	7,856	[1]
Private Placement Warrants | Derivative Warrant Liabilities [Member]
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]
Balance—December 31, 2021	0
Initial measurement on March 2, 2022 upon Business Combination (Note 3)	9,612
Change in fair values	(3,070)	[1]
Extinguishment due to exercise of the warrants	0
Balance—June 30, 2022	6,542	[1]
Trinity Warrants [Member] | Derivative Warrant Liabilities [Member]
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]
Balance—December 31, 2021	4,355
Change in fair values	2,015	[1]
Extinguishment due to exercise of the warrants	(6,370)
Balance—June 30, 2022	$ 0	[1]
[1]For discussion on the restatement adjustments, see Note 1 — Description of Business — Restatement of Condensed Consolidated Financial Statements and Immaterial Correction of Prior-Period Errors

Equity Plans -Schedule Of Share

Equity Plans -Schedule Of Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Grant Date Intrinsic Value (Detail) - USD ($) $ / shares in Units, $ in Thousands	6 Months Ended		12 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Dec. 31, 2021
Outstanding	11,468,275
Granted	0
Exercised	(1,353,145)
Forfeited and expired	(632,419)
Outstanding	9,482,711		11,468,275
Exercisable	5,874,426
Outstanding	$ 0.36
Exercised	0.27
Forfeited and expired	0.27
Outstanding	0.35		$ 0.36
Exercisable	$ 0.39
Outstanding	7 years 8 months 12 days		8 years 1 month 6 days
Outstanding	7 years 8 months 12 days		8 years 1 month 6 days
Exercisable	7 years 8 months 12 days
Outstanding	$ 46,839
Exercised	7,104	$ 500
Outstanding	31,454		$ 46,839
Exercisable	$ 19,258

Equity Plans - Schedule of Acti

Equity Plans - Schedule of Activity Related to Restricted Stock Units (Detail)	6 Months Ended
	Jun. 30, 2022 $ / shares shares
Schedule Of Share Based Compensation Restricted Stock And Restricted Stock Units Activity [Line Items]
Beginning balance	5,388,455
Number of Restricted Stock Units, Granted	9,885,413
Number of Restricted Stock Units, Vested	(2,630,699)
Number of Restricted Stock Units, Forfeited	(792,643)
Ending balance	11,850,526
Weighted-Average Fair Value Per Share, Granted | $ / shares	$ 4.89

Equity Plans -Schedule Of Emplo

Equity Plans -Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs (Detail) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Share-based Payment Arrangement, Expense	$ 11,041	$ 521	$ 22,522	$ 1,118
Research And Development Expense
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Share-based Payment Arrangement, Expense	2,209	299	4,598	638
Selling and Marketing Expense [Member]
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Share-based Payment Arrangement, Expense	256	29	697	61
General and Administrative Expense [Member]
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Share-based Payment Arrangement, Expense	$ 8,576	$ 193	$ 17,227	$ 419

Equity Plans -Schedule Of Sha_2

Equity Plans -Schedule Of Share Based Payment Award Stock Options Valuation Assumptions (Detail)	6 Months Ended
	Jun. 30, 2022 $ / shares
Expected volatility	46.80%
Weighted-average risk-free interest rate	1.07%
Expected dividend yield	0%
Expected term (in years)	6 years 1 month 6 days
Exercise price	$ 0.21

Equity Plans - Additional Infor

Equity Plans - Additional Information (Detail) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant	18,332,215		18,332,215
Stock-based compensation expense	$ 11,041	$ 521	$ 22,522	$ 1,118
weighted-average grant date fair value of options granted				$ 0.09
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value			7,104	$ 500
Amount of cost not yet recognized for nonvested award	1,900		$ 1,900
Weighted-average period over which cost not yet recognized			1 year 8 months 12 days
Vested			2,630,699
Restricted Stock Units RSU
Stock-based compensation expense	10,700	0	$ 21,900	0
Amount of cost not yet recognized for nonvested award	49,100		$ 49,100
Weighted-average period over which cost not yet recognized			2 years 2 months 26 days
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value			$ 12,900	0
Restricted Stock Awards
Stock-based compensation expense	$ 623	$ 0	$ 623	$ 0
Vested			120,000
2022 Equity Incentive Plan
Percentage of the common stock of all classes outstanding on preceding year			5%

Net Loss Per Share - Schedule o

Net Loss Per Share - Schedule of Earnings Per Share Basic and Diluted (Detail) - USD ($)		3 Months Ended			6 Months Ended
		Jun. 30, 2022		Jun. 30, 2021	Jun. 30, 2022		Jun. 30, 2021
Net loss	[1]	$ (12,252)		$ (10,074)	$ (29,894)		$ (17,861)
Weighted-average Class A Common Stock outstanding, Basic	[2]	114,096,390	[1]	21,977,123	84,060,966	[1]	21,912,665
Weighted-average Class A Common Stock outstanding, Diluted	[2]	114,096,390	[1]	21,977,123	84,060,966	[1]	21,912,665
Basic		$ (0.11)		$ (0.46)	$ (0.36)		$ (0.82)
Diluted		$ (0.11)		$ (0.46)	$ (0.36)		$ (0.82)
Class A Ordinary Shares
Weighted-average Class A Common Stock outstanding, Basic		114,096,390		21,977,123	84,060,966		21,912,665
Weighted-average Class A Common Stock outstanding, Diluted		114,096,390		21,977,123	84,060,966		21,912,665
Basic	[1]	$ (0.11)		$ (0.46)	$ (0.36)		$ (0.82)
Diluted	[1]	$ (0.11)		$ (0.46)	$ (0.36)		$ (0.82)
[1]For discussion on the restatement adjustments, see Note 1 — Description of Business — Restatement of Condensed Consolidated Financial Statements and Immaterial Correction of Prior-Period Errors[2]Weighted-average shares have been retroactively restated to give effect to the Business Combination.

Net Loss Per Share - Schedule_2

Net Loss Per Share - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Detail) - Common Class A [Member] - shares		6 Months Ended
		Jun. 30, 2022	Jun. 30, 2021
Antidilutive Securities Excluded From Computation Of Earnings Per Warrant Amount		35,509,303	92,382,798
Convertible Series C-1 Preferred Stock
Antidilutive Securities Excluded From Computation Of Earnings Per Warrant Amount	[1]	0	23,218,418
Convertible Series C Preferred Stock
Antidilutive Securities Excluded From Computation Of Earnings Per Warrant Amount	[1]	0	54,478,261
Warrants
Antidilutive Securities Excluded From Computation Of Earnings Per Warrant Amount	[1],[2]	14,176,066	1,890,514
Employee Stock Option Member
Antidilutive Securities Excluded From Computation Of Earnings Per Warrant Amount	[1]	9,482,711	12,795,605
Restricted Stock Units RSU
Antidilutive Securities Excluded From Computation Of Earnings Per Warrant Amount	[1]	11,850,526	0
[1]The number of outstanding shares as of June 30, 2021 have been retrospectively adjusted to reflect the Exchange Ratio.[2]The number of outstanding warrants as of June 30, 2022 and June 30, 2021 does not include 1,608,370 shares of Unvested Customer Warrants.

Net Loss Per Share - Schedule_3

Net Loss Per Share - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Parenthetical) (Detail) - shares	6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Unvested Customer Warrants [Member]
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount	1,608,370	1,608,370

Net Loss Per Share - Additional

Net Loss Per Share - Additional Informtion (Detail) - $ / shares		3 Months Ended			6 Months Ended
		Jun. 30, 2022		Jun. 30, 2021	Jun. 30, 2022		Jun. 30, 2021
Weighted average number of shares Contingently Issuable shares under earnout arrangement					3,059,273
Weighted-average common shares outstanding - Basic	[2]	114,096,390	[1]	21,977,123	84,060,966	[1]	21,912,665
Weighted-average common shares outstanding - Diluted	[2]	114,096,390	[1]	21,977,123	84,060,966	[1]	21,912,665
Warrant [Member]
Exercise price common stock of warrants or rights outstanding		$ 0.01		$ 0.01	$ 0.01		$ 0.01
Weighted-average common shares outstanding - Basic		2,683,830		5,237,367	3,326,508		5,245,876
Weighted-average common shares outstanding - Diluted		2,683,830		5,237,367	3,326,508		5,245,876
[1]For discussion on the restatement adjustments, see Note 1 — Description of Business — Restatement of Condensed Consolidated Financial Statements and Immaterial Correction of Prior-Period Errors[2]Weighted-average shares have been retroactively restated to give effect to the Business Combination.

Segments - Summary of Revenue b

Segments - Summary of Revenue by Geography (Detail) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenues	$ 2,134	$ 1,540	$ 4,238	$ 3,900
Revenue from Rights Concentration Risk [Member] | Revenue Benchmark [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Concentration Risk, Percentage	100%	100%	100%	100%
US
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenues	$ 1,649	$ 593	$ 3,550	$ 2,783
US | Revenue from Rights Concentration Risk [Member] | Revenue Benchmark [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Concentration Risk, Percentage	77.30%	38.50%	83.80%	71.40%
GB
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenues	$ 485	$ 947	$ 688	$ 1,117
GB | Revenue from Rights Concentration Risk [Member] | Revenue Benchmark [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Concentration Risk, Percentage	22.70%	61.50%	16.20%	28.60%

Subsequent Events - Additional

Subsequent Events - Additional Information (Detail) - USD ($) $ in Millions	Aug. 11, 2022	Jun. 30, 2022	Dec. 31, 2021
Subsequent Event [Line Items]
Common stock, issued		117,102,735	18,221,069
Common stock, outstanding		117,102,735	18,221,069
Subsequent Event [Member]
Subsequent Event [Line Items]
Percentage of the aggregate number of shares of common stock issued and outstanding immediately prior to the execution of the agreement.	19.99%
Common stock, issued	23,648,889
Common stock, outstanding	23,648,889
Subsequent Event [Member] | Common Stock Purchase Agreement [Member]
Subsequent Event [Line Items]
Stock Issued During Period, Shares, Issued for Services	171,008
Subsequent Event [Member] | Common Stock Purchase Agreement [Member] | Common Class A [Member]
Subsequent Event [Line Items]
Common stock value subscriptions may issue and sell to investor	$ 75